
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Malaria - Infectious Diseases - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "41d23fd9-b669-405d-96af-4b99d8814c55";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1016413";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "2cca5623-acf6-431c-a815-3109d2d64fa3",
 VasontId : "v1015929"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "31b9cca6-b744-4d01-a4c5-6642dd6c8f29",
 VasontId : "v878841"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="41d23fd9-b669-405d-96af-4b99d8814c55">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = 'ad9a34b5-e470-4ae4-9f71-11cf600d9612';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Malaria
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/marie-chelsea.html">Chelsea Marie</a></strong>
 <p class="topic__authors--description">, PhD, University of Virginia;</p>
 <br>
 <strong class="topic__label topic__label--author"><a href="./Contributors/petri-william.html">William A. Petri, Jr</a></strong>
 <p class="topic__authors--description">, MD, PhD, University of Virginia School of Medicine</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Dec 2022 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="084" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1016436" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v1016519" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1016556" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1016696" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v11146950" class="topicmenu_mobile__paragraph">Prevention of Relapses of <i>P. vivax</i> or <i>P. ovale</i> Malaria</a>
 </li>
 <li>
 <a href="#v1017334" class="topicmenu_mobile__paragraph">Prevention</a>
 </li>
 <li>
 <a href="#v11147157" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v43460806" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Calculators'); }, keypress: function() { $data.activateGroup('Calculators'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Calculators (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--calculator" data-group-name="calculator" title="QT Interval Correction (EKG)">
 <div class="hero__excerpt">
 <img class="hero__excerpt--image" src="./Content/Images/Redesign/calculator/icon_calculator_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 QT Interval Correction (EKG)
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"IframeSrc":"/medical-calculators/QTIntervalCorrection.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"3ecc18fc-1e08-4abe-9722-5bb7a2fc62e9","Title":"QT%20Interval%20Correction%20%28EKG%29","ShareUrlTitle":"qt-interval-correction-ekg","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical%20Calculator","UniqueId":null,"Placement":null,"IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"QT%20Interval%20Correction%20%28EKG%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Clinical%20Calculator","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (1)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Plasmodium Life Cycle">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?mw=350&amp;thn=0&amp;sc_lang=en" width="600" height="481" loading="lazy">
 </div>
 <span class="hero__description">
 <i>Plasmodium</i> Life Cycle
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Plasmodium Life Cycle","Credits":"\u003cspan id=\u0022v85660754\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage from the Centers for Disease Control and Prevention Image Library.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4ed846c4-8903-4b99-9808-a346cc78ba33","Title":"%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Life%20Cycle","ShareUrlTitle":"plasmodium-life-cycle","Description":"%3Cp%3E","ImageUrl":"./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v77496489","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"600","ImageHeight":"481","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Life%20Cycle","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (4)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Diagnostic Features of Plasmodium Species in Blood Smears">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Diagnostic Features of <i>Plasmod...</i>
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"4189f7ef-aae1-47bd-92ad-da2c97ffd2e6","Title":"Diagnostic%20Features%20of%20%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Species%20in%20Blood%20Smears","ShareUrlTitle":"diagnostic-features-of-plasmodium-species-in-blood-smears","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249347","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Diagnostic%20Features%20of%20%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Species%20in%20Blood%20Smears","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Treatment of Malaria in the United States">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Treatment of Malaria in the...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"7d93d67f-f973-4622-8b96-c7712ceee420","Title":"Treatment%20of%20Malaria%20in%20the%20United%20States","ShareUrlTitle":"treatment-of-malaria-in-the-united-states","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249483","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Treatment%20of%20Malaria%20in%20the%20United%20States","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Adverse Reactions and Contraindications of Antimalarial Drugs">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Adverse Reactions and Contraindic...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Drugs Used to Prevent Malaria">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Drugs Used to Prevent Malaria
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Drugs%20Used%20to%20Prevent%20Malaria","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1016429" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Malaria is infection with <i>Plasmodium</i> species. Symptoms and signs include fever (which may be periodic), chills, rigors, sweating, diarrhea, abdominal pain, respiratory distress, confusion, seizures, hemolytic anemia, splenomegaly, and renal abnormalities. Diagnosis is by seeing <i>Plasmodium</i> in a peripheral blood smear and by rapid diagnostic tests. Treatment and prophylaxis depend on the <i>Plasmodium</i> species and drug sensitivity and the patient's clinical status. Treatment regimens for acute disease include artemisinin-based combination therapy, the most rapidly acting regimen, the fixed combination of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> and proguanil, and, less commonly, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span>, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>. Patients infected with <i>P. vivax</i> and <i>P. ovale</i> also receive <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> to prevent relapse. Prophylaxis is usually with the fixed combination of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> plus proguanil or with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span>; <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> is used in areas without <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> resistance. Terminal treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is given to patients likely to have been exposed to <i>P. vivax</i> or <i>P. ovale</i>.</div></p></div><span id="v1016435" class="anchor"></span><div class="para"> <p>Malaria is infection with <i>Plasmodium</i> species. About half of the world’s population is at risk of malaria. Malaria is endemic in Africa, India and other areas of South Asia, Southeast Asia, North and South Korea, Mexico, Central America, Haiti, the Dominican Republic, South America (including northern parts of Argentina), the Middle East (including Turkey, Syria, Iran, and Iraq), and Central Asia. The Centers for Disease Control and Prevention (CDC) provides information about specific countries where malaria is transmitted (see <a rel="nofollow" target="_blank" href="https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/yellow-fever-malaria-information-by-country">CDC: Yellow Fever and Malaria Information, by Country</a>), types of malaria, resistance patterns, and recommended prophylaxis (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/malaria/">CDC: Malaria</a>).</p></div><span id="v11146537" class="anchor"></span><div class="para"> <p>In 2020, there were an estimated 241 million cases of malaria, with 95% of them in Africa (see <a rel="nofollow" target="_blank" href="https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2021">2021 World Malaria Report</a>). An estimated 627,000 people died from malaria in 2020, mostly children < 5 years of age. Since 2000, deaths due to malaria have decreased by approximately 30% through the efforts of the <a rel="nofollow" target="_blank" href="https://endmalaria.org/">RBM (Roll Back Malaria) Partnership to End Malaria</a>, which has > 500 partners (including endemic countries and various organizations and institutions). Despite decades of decline, the number of deaths increased in 2020 as a result of disruptions due to the COVID-19 pandemic.</p></div><span id="v29655908" class="anchor"></span><div class="para"> <p>Malaria once was endemic in the US. Currently, about 1500 cases occur in the US each year. Nearly all are acquired abroad, but a small number result from blood transfusions or rarely from transmission by local mosquitoes that feed on infected immigrants or returning travelers.</p></div> <section id="v1016436" class="topic__section FHead"> <h2 id="Pathophysiology_v1016437" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v1016437" class="anchor"></span> Pathophysiology of Malaria </h2> <div class="topic__content"> <span id="v1016438" class="anchor"></span><div class="para"> <p>The <i>Plasmodium</i> species that infect humans are</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1016442" class="anchor"></span><div class="para"> <p><i>P. falciparum</i></p></div></li><li class="topic__listitem"><span id="v1016445" class="anchor"></span><div class="para"> <p><i>P. vivax</i></p></div></li><li class="topic__listitem"><span id="v1016448" class="anchor"></span><div class="para"> <p><i>P. ovale</i></p></div></li><li class="topic__listitem"><span id="v1016451" class="anchor"></span><div class="para"> <p><i>P. malariae</i></p></div></li><li class="topic__listitem"><span id="v11146552" class="anchor"></span><div class="para"> <p><i>P. knowlesi</i></p></div></li></ul></div><span id="v1016453" class="anchor"></span><div class="para"> <p>Concurrent infection with more than one <i>Plasmodium</i> species is uncommon but can occur.</p></div><span id="v11146561" class="anchor"></span><div class="para"> <p><i>P. knowlesi</i> is a pathogen in Southeast Asia, particularly in Malaysia. Macaque monkeys are the primary hosts. <i>P. knowlesi</i> is usually acquired by people living or working near or in forests. </p></div><span id="v1016456" class="anchor"></span><div class="para"> <p>The basic elements of the life cycle are the same for all <i>Plasmodium</i> species. Transmission begins when a female <i>Anopheles</i> mosquito feeds on a person with malaria and ingests blood containing gametocytes.</p></div><span id="v29655909" class="anchor"></span><div class="para"> <p>During the following 1 to 2 weeks, gametocytes inside the mosquito reproduce sexually and produce infective sporozoites. When the mosquito feeds on another human, sporozoites are inoculated and quickly reach the liver and infect hepatocytes.</p></div><span id="v29655910" class="anchor"></span><div class="para"> <p>The parasites mature into tissue schizonts within hepatocytes. Each schizont produces 10,000 to 30,000 merozoites, which are released into the bloodstream 1 to 3 weeks later when the hepatocyte ruptures. Each merozoite can invade a red blood cell (RBC) and there transform into a trophozoite.</p></div><span id="v29655911" class="anchor"></span><div class="para"> <p>Trophozoites grow, and most develop into erythrocyte schizonts; schizonts produce further merozoites, which 48 to 72 hours later rupture the RBC and are released in plasma. These merozoites then rapidly invade new RBCs, repeating the cycle. Some trophozoites develop into gametocytes, which are ingested by an <i>Anopheles</i> mosquito. They undergo sexual union in the gut of the mosquito, develop into oocysts, and release infective sporozoites, which migrate to the salivary glands.</p></div> <div class="inlinemedia-component " data-ko-rebind="v77496489" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Plasmodium Life Cycle","Credits":"\u003cspan id=\u0022v85660754\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eImage from the Centers for Disease Control and Prevention Image Library.\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4ed846c4-8903-4b99-9808-a346cc78ba33","Title":"\u003ci \u003ePlasmodium\u003c/i\u003e Life Cycle","ShareUrlTitle":"plasmodium-life-cycle","Description":"\u003cul\u003e\u003cspan id=\u0022v88840937\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v77496489","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"600","ImageHeight":"481","IframeSrc":null,"Target":null}'> </div><span id="v1016498" class="anchor"></span><div class="para"> <p>With <i>P. vivax</i> and <i>P. ovale</i> (but not <i>P. falciparum</i> or <i>P. malariae</i>), tissue schizonts may persist as hypnozoites in the liver for years. Relapse of <i>P. ovale</i> has occurred as late as 6 years after an episode of symptomatic malaria, and the infection was transmitted by blood transfusion from a person who was exposed 7 years before donating blood. These dormant forms serve as time-release capsules, which cause relapses and complicate chemotherapy because they are not killed by most antimalarial drugs, which typically act on bloodstream parasites.</p></div><span id="v1016503" class="anchor"></span><div class="para"> <p>The pre-erythrocytic (hepatic) stage of the malarial life cycle is bypassed when infection is transmitted by blood transfusions, by sharing of contaminated needles, or congenitally. Therefore, these modes of transmission do not cause latent disease or delayed recurrences.</p></div><span id="v1016504" class="anchor"></span><div class="para"> <p>Rupture of RBCs during release of merozoites is associated with the clinical symptoms. If severe, <a href="./{26F34E48-2271-425D-B495-01426A68163C}.html" data-toggle="tooltip" title="Overview of Hemolytic Anemia" data-id="ec42800c-3435-4683-abfc-e310eaf388e3" data-itemid="26f34e48-2271-425d-b495-01426a68163c">hemolysis</a><span id="ec42800c-3435-4683-abfc-e310eaf388e3" class="d-none xref"> <span class="tooltip-container"> <a href="./{26F34E48-2271-425D-B495-01426A68163C}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Overview of Hemolytic Anemia </span> At the end of their normal life span (about 120 days), red blood cells (RBCs) are removed from the circulation. Hemolysis is defined as premature destruction and hence a shortened RBC life span... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/p/h/spherocytes_hemolytic_anemia_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Overview of Hemolytic Anemia" loading="lazy"> </span> </a> </span> </span> causes anemia and jaundice, which are worsened by phagocytosis of infected RBCs in the spleen. Anemia may be severe in <i>P. falciparum</i> or chronic <i>P. vivax</i> infection but tends to be mild in <i>P. malariae</i> infection.</p></div> <section id="v1016508" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1016437_v1016509" class="topic__header--subsection"> <span id="v1016509" class="anchor"></span> Falciparum malaria </h3> <div class="topic__content"> <span id="v1016510" class="anchor"></span><div class="para"> <p>Unlike other forms of malaria, <i>P. falciparum</i> causes microvascular obstruction because infected RBCs adhere to vascular endothelial cells. Ischemia can develop with resultant tissue hypoxia, particularly in the brain, kidneys, lungs, and gastrointestinal tract. Hypoglycemia and lactic acidosis are other potential complications.</p></div> </div> </section> <section id="v1016512" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1016437_v1016513" class="topic__header--subsection"> <span id="v1016513" class="anchor"></span> Resistance to infection </h3> <div class="topic__content"> <span id="v1016514" class="anchor"></span><div class="para"> <p>Most West Africans have complete resistance to <i>P. vivax</i> because their RBCs lack the Duffy blood group, which is involved in attachment of <i>P. vivax</i> to RBCs; many African Americans also have such resistance. The development of <i>Plasmodium</i> in RBCs is retarded in patients with <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html" data-toggle="tooltip" title="Sickle Cell Disease" data-id="f63d52ec-197b-45d9-bad8-2730c9cce270" data-itemid="7bc15747-85ec-4626-b72a-56c6c28000b8">hemoglobin S disease</a><span id="f63d52ec-197b-45d9-bad8-2730c9cce270" class="d-none xref"> <span class="tooltip-container"> <a href="./{7BC15747-85EC-4626-B72A-56C6C28000B8}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Sickle Cell Disease </span> Sickle cell disease (a hemoglobinopathy) causes a chronic hemolytic anemia occurring almost exclusively in people with African ancestry. It is caused by homozygous inheritance of genes for hemoglobin... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/i/c/sickle_cells_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Sickle Cell Disease" loading="lazy"> </span> </a> </span> </span>, <a href="./{1DEF6132-8C48-4E61-B5FD-FF7E8ABC4671}.html" data-toggle="tooltip" title="Hemoglobin C Disease" data-id="b44a5ae5-a409-4280-b509-e797ac62dd42" data-itemid="1def6132-8c48-4e61-b5fd-ff7e8abc4671">hemoglobin C disease</a><span id="b44a5ae5-a409-4280-b509-e797ac62dd42" class="d-none xref"> <span class="tooltip-container"> <a href="./{1DEF6132-8C48-4E61-B5FD-FF7E8ABC4671}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hemoglobin C Disease </span> Hemoglobin C disease is a hemoglobinopathy that causes symptoms of a hemolytic anemia. (See also Overview of Hemolytic Anemia.) The prevalence of detectable hemoglobin (Hb) C in people in the... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{DAE5875D-713F-4EE5-8434-9A9830DE6CC2}.html" data-toggle="tooltip" title="Thalassemias" data-id="900dc927-d0b8-47df-ac8d-ec66599b5631" data-itemid="dae5875d-713f-4ee5-8434-9a9830de6cc2">thalassemia</a><span id="900dc927-d0b8-47df-ac8d-ec66599b5631" class="d-none xref"> <span class="tooltip-container"> <a href="./{DAE5875D-713F-4EE5-8434-9A9830DE6CC2}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Thalassemias </span> Thalassemias are a group of inherited microcytic, hemolytic anemias characterized by defective hemoglobin synthesis. Alpha-thalassemia is particularly common among people with African, Mediterranean... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, <a href="./{0954353A-CDE3-4BBF-BF05-1E94E4A1D441}.html" data-toggle="tooltip" title="Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency" data-id="54a0c3ce-b364-40c2-a099-eafe0b625d85" data-itemid="0954353a-cde3-4bbf-bf05-1e94e4a1d441">G6PD deficiency</a><span id="54a0c3ce-b364-40c2-a099-eafe0b625d85" class="d-none xref"> <span class="tooltip-container"> <a href="./{0954353A-CDE3-4BBF-BF05-1E94E4A1D441}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency </span> Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked enzymatic defect common in people with African ancestry that can result in hemolysis after acute illnesses or intake of oxidant... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/r/e/d/red-g6pd-deficiency-spivak-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency" loading="lazy"> </span> </a> </span> </span>, or <a href="./{98231ACF-0F5A-425D-AE43-BB10DE934BCD}.html" data-toggle="tooltip" title="Hereditary Spherocytosis and Hereditary Elliptocytosis" data-id="ff0cfb68-7aa1-4ac9-93a8-835a094a4e17" data-itemid="98231acf-0f5a-425d-ae43-bb10de934bcd">elliptocytosis</a><span id="ff0cfb68-7aa1-4ac9-93a8-835a094a4e17" class="d-none xref"> <span class="tooltip-container"> <a href="./{98231ACF-0F5A-425D-AE43-BB10DE934BCD}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Hereditary Spherocytosis and Hereditary Elliptocytosis </span> Hereditary spherocytosis and hereditary elliptocytosis are congenital red blood cell (RBC) membrane disorders that can cause a mild hemolytic anemia. Symptoms, generally milder in hereditary... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/s/p/h/spherocytes_hemolytic_anemia_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Hereditary Spherocytosis and Hereditary Elliptocytosis" loading="lazy"> </span> </a> </span> </span>.</p></div><span id="v1016518" class="anchor"></span><div class="para"> <p>Previous infections provide partial immunity. Once residents of hyperendemic areas leave, acquired immunity wanes over time (months to years), and symptomatic malaria may develop if they return home and become reinfected.</p></div> </div> </section> </div> </section> <section id="v1016519" class="topic__section FHead"> <h2 id="SymptomsAndSigns_v1016520" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1016520" class="anchor"></span> Symptoms and Signs of Malaria </h2> <div class="topic__content"> <span id="v1016521" class="anchor"></span><div class="para"> <p>The <b>incubation period</b> is usually</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29655916" class="anchor"></span><div class="para"> <p>12 to 17 days for <i>P. vivax</i></p></div></li><li class="topic__listitem"><span id="v29655919" class="anchor"></span><div class="para"> <p>9 to 14 days for <i>P. falciparum</i></p></div></li><li class="topic__listitem"><span id="v29655922" class="anchor"></span><div class="para"> <p>16 to 18 days or longer for <i>P. ovale</i></p></div></li><li class="topic__listitem"><span id="v29655925" class="anchor"></span><div class="para"> <p>About 1 month (18 to 40 days) or longer (years) for <i>P. malariae</i></p></div></li></ul></div><span id="v29655927" class="anchor"></span><div class="para"> <p>However, some strains of <i>P. vivax</i> in temperate climates may not cause clinical illness for months to <span class='symbol'>></span> 1 year after infection.</p></div><span id="v1016527" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>Manifestations common to all forms of malaria</b> include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1016530" class="anchor"></span><div class="para"> <p>Fever and rigors—the malarial paroxysm</p></div></li><li class="topic__listitem"><span id="v1016532" class="anchor"></span><div class="para"> <p>Anemia</p></div></li><li class="topic__listitem"><span id="v1016534" class="anchor"></span><div class="para"> <p>Jaundice</p></div></li><li class="topic__listitem"><span id="v1016536" class="anchor"></span><div class="para"> <p>Splenomegaly</p></div></li><li class="topic__listitem"><span id="v1016538" class="anchor"></span><div class="para"> <p>Hepatomegaly</p></div></li></ul></div><span id="v1016539" class="anchor"></span><div class="para"> <p>Malarial paroxysm is caused by hemolysis of infected RBCs, released merozoites and other malaria antigens, and the inflammatory response they elicit. The classic paroxysm starts with malaise, abrupt chills and fever rising to 39 to 41<span class='symbol'>°</span> C, rapid and thready pulse, polyuria, headache, myalgia, and nausea. After 2 to 6 hours, fever falls, and profuse sweating occurs for 2 to 3 hours, followed by extreme fatigue. Fever is often hectic at the start of infection. In established infections, malarial paroxysms typically occur every 2 to 3 days depending on the species.</p></div><span id="v1016541" class="anchor"></span><div class="para"> <p>Splenomegaly usually becomes palpable by the end of the first week of clinical disease but may not occur with <i>P. falciparum</i>. The enlarged spleen is soft and prone to traumatic rupture. Splenomegaly may decrease with recurrent attacks of malaria as functional immunity develops. After many bouts, the spleen may become fibrotic and firm or, in some patients, becomes massively enlarged (tropical splenomegaly). Hepatomegaly usually accompanies splenomegaly.</p></div> <section id="v29655929" class="topic__section GHead"> <span></span> <h3 id="SymptomsAndSigns_v1016520_v29655930" class="topic__header--subsection"> <span id="v29655930" class="anchor"></span> <i>P. falciparum</i> manifestations </h3> <div class="topic__content"> <span id="v29655932" class="anchor"></span><div class="para"> <p><i>P. falciparum</i> causes the most severe disease because of its microvascular effects. It is the only species likely to cause fatal disease if untreated; nonimmune patients may die within days of their initial symptoms. Temperature spikes and accompanying symptoms typically occur in an irregular pattern but can become synchronous, occurring in a tertian pattern (temperature spikes at 48-hour intervals), particularly in residents of endemic areas who are partially immune.</p></div><span id="v29655934" class="anchor"></span><div class="para"> <p>Patients with cerebral malaria may develop symptoms ranging from irritability to seizures and coma. <a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html" data-toggle="tooltip" title="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" data-id="76646f68-af91-4770-8879-13443b4ab0a7" data-itemid="e5694a16-9f21-42da-9472-818020af6c25">Acute respiratory distress syndrome</a><span id="76646f68-af91-4770-8879-13443b4ab0a7" class="d-none xref"> <span class="tooltip-container"> <a href="./{E5694A16-9F21-42DA-9472-818020AF6C25}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Acute Hypoxemic Respiratory Failure (AHRF, ARDS) </span> Acute hypoxemic respiratory failure is defined as severe hypoxemia (PaO2 (See also Overview of Mechanical Ventilation.) Airspace filling in acute hypoxemic respiratory failure (AHRF) may result... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/p/u/l/pulmonary_edema_high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Acute Hypoxemic Respiratory Failure (AHRF, ARDS)" loading="lazy"> </span> </a> </span> </span> (ARDS), diarrhea, icterus, epigastric tenderness, retinal hemorrhages, algid malaria (a shocklike syndrome), and severe thrombocytopenia may also occur.</p></div><span id="v29655935" class="anchor"></span><div class="para"> <p>Renal insufficiency may result from volume depletion, vascular obstruction by parasitized erythrocytes, or immune complex deposition. Hemoglobinemia and hemoglobinuria resulting from intravascular hemolysis may progress to blackwater fever (so named based on the dark color of the urine), either spontaneously or after treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span>.</p></div><span id="v29655937" class="anchor"></span><div class="para"> <p>Hypoglycemia is common and may be aggravated by <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> treatment and associated hyperinsulinemia.</p></div><span id="v29655938" class="anchor"></span><div class="para"> <p>Placental involvement may lead to low birth weight, spontaneous abortion, stillbirth, or congenital infection.</p></div> </div> </section> <section id="v29655939" class="topic__section GHead"> <span></span> <h3 id="SymptomsAndSigns_v1016520_v29655940" class="topic__header--subsection"> <span id="v29655940" class="anchor"></span> <i>P. vivax</i>, <i>P. ovale</i>, <i>P. malariae</i>, and <i>P. knowlesi</i> manifestations </h3> <div class="topic__content"> <span id="v29655943" class="anchor"></span><div class="para"> <p><i>P. vivax</i>, <i>P. ovale</i>, and <i>P. malariae</i> typically do not compromise vital organs. Mortality is rare and is mostly due to splenic rupture or uncontrolled hyperparasitemia in asplenic patients.</p></div><span id="v29655946" class="anchor"></span><div class="para"> <p>The clinical course with <i>P. ovale</i> is similar to that of <i>P. vivax</i>. In established infections, temperature spikes occur at 48-hour intervals—a tertian pattern.</p></div><span id="v29655949" class="anchor"></span><div class="para"> <p><i>P. malariae</i> infections may cause no acute symptoms, but low-level parasitemia may persist for decades and lead to immune complex–mediated nephritis or nephrosis or tropical splenomegaly; when symptomatic, fever tends to occur at 72-hour intervals—a quartan pattern.</p></div><span id="v50500061" class="anchor"></span><div class="para"> <p><i>P. knowlesi</i> is associated with the full spectrum of malaria. In contrast to <i>P. falciparum</i>, infection is more likely in males over 15 years living close to or working in forested areas. There are typically daily temperature spikes. Severity increases with the patient's age. The short asexual replication cycle of 24 hours can lead to high rates of parasitemia, and if untreated, death. Thrombocytopenia is common, but it is typically not associated with hemorrhage. </p></div> </div> </section> <section id="v29655951" class="topic__section GHead"> <span></span> <h3 id="SymptomsAndSigns_v1016520_v29655952" class="topic__header--subsection"> <span id="v29655952" class="anchor"></span> Manifestations in patients taking chemoprophylaxis </h3> <div class="topic__content"> <span id="v29655953" class="anchor"></span><div class="para"> <p>In patients who have been taking chemoprophylaxis (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDrugs%20Used%20to%20Prevent%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>), malaria may be atypical. The incubation period may extend weeks to months after the drug is stopped. Those infected may develop headache, backache, and irregular fever, but parasites may initially be difficult to find in blood samples.</p></div> </div> </section> </div> </section> <section id="v1016556" class="topic__section FHead"> <h2 id="Diagnosis_v1016557" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1016557" class="anchor"></span> Diagnosis of Malaria </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1016561" class="anchor"></span><div class="para"> <p>Light microscopy of blood (thin and thick smears)</p></div></li><li class="topic__listitem"><span id="v1016563" class="anchor"></span><div class="para"> <p>Rapid diagnostic tests that detect <i>Plasmodium</i> antigens or enzymes in blood</p></div></li></ul></div><span id="v1016565" class="anchor"></span><div class="para"> <p>Fever and chills in an immigrant or traveler returning from an endemic region should prompt immediate assessment for malaria. Symptoms usually appear in the first 6 months after infection, but onset may take up to 2 years or, rarely, longer.</p></div><span id="v1016566" class="anchor"></span><div class="para"> <p>Malaria can be diagnosed by finding parasites on microscopic examination of thick or thin blood smears. The infecting species (which determines therapy and prognosis) is identified by characteristic features on smears (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"4189f7ef-aae1-47bd-92ad-da2c97ffd2e6","Title":"Diagnostic%20Features%20of%20Plasmodium%20Species%20in%20Blood%20Smears","ShareUrlTitle":"diagnostic-features-of-plasmodium-species-in-blood-smears","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249347","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDiagnostic%20Features%20of%20Plasmodium%20Species%20in%20Blood%20Smears%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). If the initial blood smear is negative, additional smears should be repeated at 12- to 24-hour intervals until 3 smears are negative.</p></div><span id="v1016568" class="anchor"></span><div class="para"> <p>Thin blood smears stained with Wright-Giemsa stain allow assessment of parasite morphology within red blood cells (RBCs), often speciation, and determination of percentage parasitemia (parasite density), evaluated using oil immersion magnification of portions of the smear where RBCs are more or less touching, which should show about 400 RBCs per field. Thick smears are more sensitive but more difficult to prepare and interpret as the RBCs are lysed before staining. Sensitivity and accuracy of the results depend on the examiner's experience.</p></div><span id="v1016569" class="anchor"></span><div class="para"> <p>Commercial rapid diagnostic tests for malaria are based on the presence of certain plasmodium antigens or enzymatic activities. Assays may involve detection of a histidine-rich protein 2 (HRP-2) associated with malaria parasites (especially <i>P. falciparum</i>) and detection of plasmodium-associated lactate dehydrogenase (pLDH). The rapid diagnostic tests are generally comparable in sensitivity to microscopy in detecting low levels of parasitemia, but they do not differentiate single infection from concurrent infection with more than one <i>Plasmodium</i> species or allow speciation except for <i>P. falciparum</i>.</p></div><span id="v1016572" class="anchor"></span><div class="para"> <p>Light microscopy and rapid diagnostic tests are complementary, and both should be done when available. They have similar sensitivity. Negative results even in both does not exclude malaria in a patient with low parasitemia.</p></div><span id="v11146656" class="anchor"></span><div class="para"> <p>Polymerase chain reaction and species-specific DNA probes can be used but are not widely available at the point of care. They can help identify the infecting <i>Plasmodium</i> species after malaria is diagnosed. Because serologic tests may reflect prior exposure, they are not useful in the diagnosis of acute malaria.</p></div> <span id="v1016573"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1016577"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"4189f7ef-aae1-47bd-92ad-da2c97ffd2e6","Title":"Diagnostic%20Features%20of%20%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Species%20in%20Blood%20Smears","ShareUrlTitle":"diagnostic-features-of-plasmodium-species-in-blood-smears","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249347","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Diagnostic%20Features%20of%20%3Ci%20%3EPlasmodium%3C%2Fi%3E%20Species%20in%20Blood%20Smears","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="4189f7ef-aae1-47bd-92ad-da2c97ffd2e6"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '4189f7ef-aae1-47bd-92ad-da2c97ffd2e6' }, async: true, success: function (data) { $('#4189f7ef-aae1-47bd-92ad-da2c97ffd2e6').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <section id="v43460575" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1016557_v43460576" class="topic__header--subsection"> <span id="v43460576" class="anchor"></span> Severity of malaria </h3> <div class="topic__content"> <span id="v43460577" class="anchor"></span><div class="para"> <p><b>Severe malaria</b> is defined by the presence of one of more of the following clinical and laboratory features. Severe malaria tends to result from <i>P. falciparum</i>.</p></div><span id="v43460579" class="anchor"></span><div class="para"> <p>Clinical criteria for severe malaria:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v43460582" class="anchor"></span><div class="para"> <p>Acute respiratory distress syndrome/pulmonary edema</p></div></li><li class="topic__listitem"><span id="v43460584" class="anchor"></span><div class="para"> <p>Bleeding</p></div></li><li class="topic__listitem"><span id="v43460586" class="anchor"></span><div class="para"> <p>Coma or impaired consciousness</p></div></li><li class="topic__listitem"><span id="v43460588" class="anchor"></span><div class="para"> <p>Jaundice</p></div></li><li class="topic__listitem"><span id="v43460590" class="anchor"></span><div class="para"> <p>Seizures (recurrent)</p></div></li><li class="topic__listitem"><span id="v43460592" class="anchor"></span><div class="para"> <p>Shock</p></div></li></ul></div><span id="v43460593" class="anchor"></span><div class="para"> <p>Laboratory criteria for severe malaria:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v43460596" class="anchor"></span><div class="para"> <p>Anemia (severe: < 7 g/dL [70 g/L])</p></div></li><li class="topic__listitem"><span id="v43460598" class="anchor"></span><div class="para"> <p> <a href="./{18F67047-6499-41D9-B1CC-0C4290E7C571}.html" data-toggle="tooltip" title="Disseminated Intravascular Coagulation (DIC)" data-id="b28e7c17-0888-4f13-b505-c6d0ecc355fb" data-itemid="18f67047-6499-41d9-b1cc-0c4290e7c571">Disseminated intravascular coagulation</a><span id="b28e7c17-0888-4f13-b505-c6d0ecc355fb" class="d-none xref"> <span class="tooltip-container"> <a href="./{18F67047-6499-41D9-B1CC-0C4290E7C571}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Disseminated Intravascular Coagulation (DIC) </span> Disseminated intravascular coagulation (DIC) involves abnormal, excessive generation of thrombin and fibrin in the circulating blood. During the process, increased platelet aggregation and coagulation... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> (DIC)</p></div></li><li class="topic__listitem"><span id="v43460600" class="anchor"></span><div class="para"> <p>Hemoglobinuria</p></div></li><li class="topic__listitem"><span id="v43460602" class="anchor"></span><div class="para"> <p>Metabolic acidosis</p></div></li><li class="topic__listitem"><span id="v43460604" class="anchor"></span><div class="para"> <p>Parasite density > 5%</p></div></li><li class="topic__listitem"><span id="v43460606" class="anchor"></span><div class="para"> <p>Renal failure</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1016696" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1016697" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1016697" class="anchor"></span> Treatment of Malaria </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1016702" class="anchor"></span><div class="para"> <p>Antimalarial drugs </p></div></li></ul></div><span id="v11146661" class="anchor"></span><div class="para"> <p>Antimalarial drugs are chosen based on the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v29655966" class="anchor"></span><div class="para"> <p>Disease severity (clinical and laboratory criteria) </p></div></li><li class="topic__listitem"><span id="v29655968" class="anchor"></span><div class="para"> <p>Infecting <i>Plasmodium</i> species</p></div></li><li class="topic__listitem"><span id="v29655971" class="anchor"></span><div class="para"> <p>Known resistance patterns of strains in the area of acquisition</p></div></li><li class="topic__listitem"><span id="v29655973" class="anchor"></span><div class="para"> <p>Efficacy and adverse effects of drugs available</p></div></li></ul></div><span id="v29655974" class="anchor"></span><div class="para"> <p>Artemisinin-based combination therapy, such as oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span>, is the most rapidly active treatment, and in many situations, it is the treatment of choice. Resistance to artemisinins has been reported but is not yet common. </p></div><span id="v43460607" class="anchor"></span><div class="para"> <p> <a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v43460576" data-toggle="tooltip" title="Severity of malaria" data-id="a06d9136-69b4-4adb-82f8-5e21a6b341c9" data-itemid="41d23fd9-b669-405d-96af-4b99d8814c55">Severe malaria</a><span id="a06d9136-69b4-4adb-82f8-5e21a6b341c9" class="d-none xref"> <span class="tooltip-container"> <a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v43460576"> <span class="tooltip-content"> <span class="tooltip-heading"> Severity of malaria </span> Malaria is infection with <i>Plasmodium</i> species. Symptoms and signs include fever (which may be periodic), chills, rigors, sweating, diarrhea, abdominal pain, respiratory distress, confusion... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Severity of malaria" loading="lazy"> </span> </a> </span> </span> requires urgent treatment, preferably with intravenous <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span>, which is the only drug available in the US for parenteral treatment of severe malaria (or for patients who cannot take drugs orally). If <span class="genericDrug" data-showrollover="false">artesunate</span> is not immediately available, start interim oral therapy with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> sulfate (plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span> intravenously), or if nothing else is available, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>. In patients who are vomiting, an antiemetic may be helpful. Those who cannot swallow (eg, because of delirium) may be given crushed tablets of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span> through a nasogastric tube.</p></div><span id="v74931450" class="anchor"></span><div class="para"> <p>Due to the risk of progression to severe disease in patients with <i>P. falciparum</i> infection, patients should be hospitalized to monitor clinical response and to check parasite density every 12 to 24 hours until clinical presentation improves and a decrease in parasite density becomes apparent (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/malaria/diagnosis_treatment/clinicians1.html">CDC: Treatment of Malaria: Guidelines for Clinicians [United States]</a>). </p></div><span id="v74931452" class="anchor"></span><div class="para"> <p>Due to the risk of delayed hemolysis, which is a frequent complication in hyperparasitemic malaria treated with IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> (<a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v29656002" data-toggle="tooltip" title="Treatment references" data-id="63814a24-56f3-4c09-a4b1-2e0cd40e08e7" data-itemid="41d23fd9-b669-405d-96af-4b99d8814c55">1</a><span id="63814a24-56f3-4c09-a4b1-2e0cd40e08e7" class="d-none xref"> <span class="tooltip-container"> <a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v29656002"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Malaria is infection with <i>Plasmodium</i> species. Symptoms and signs include fever (which may be periodic), chills, rigors, sweating, diarrhea, abdominal pain, respiratory distress, confusion... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>), hemoglobin levels should be monitored for 4 weeks after therapy.</p></div> <a id="v43460609"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v43460611"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v43460611"></span> <div class="TableHalfPage" id="v56249473"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249482" class="anchor"></span><div class="para"> <p>Time is of the essence in treating severe malaria. Begin treatment with IV <span class="genericDrug" data-showrollover="false">artesunate</span> as soon as possible. Start interim oral therapy with other drugs if IV <span class="genericDrug" data-showrollover="false">artesunate</span> is not immediately available. </p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div><span id="v11146663" class="anchor"></span><div class="para"> <p>In some endemic areas, a significant proportion of locally available antimalarial drugs are counterfeit. Thus, some clinicians advise travelers to remote, high-risk areas to take along a full course of an appropriate treatment regimen to be used if medically confirmed malaria is acquired despite prophylaxis; this strategy also avoids depleting limited drug resources in the destination country.</p></div><span id="v1016704" class="anchor"></span><div class="para"> <p>Malaria is particularly dangerous in children <span class='symbol'>&lt</span> 5 years (mortality is highest in those <span class='symbol'>&lt</span> 2 years), pregnant women, and previously unexposed visitors to endemic areas. </p></div><span id="v29655975" class="anchor"></span><div class="para"> <p>If <i>P. falciparum</i> is suspected, therapy should be initiated immediately, even if the initial smear and rapid diagnostic test are negative. <i>P. falciparum</i> resistance to antimalarial drugs is now widespread, and <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant <i>P. vivax</i> is common in Papua New Guinea, Indonesia, and emerging in some other areas (eg, Southeast Asia, South Asia, the Middle East, East Africa, and the Americas) (<a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v29656002" data-toggle="tooltip" title="Treatment references" data-id="a5d8044d-74c3-4adf-a3f9-8662762a53c8" data-itemid="41d23fd9-b669-405d-96af-4b99d8814c55">2</a><span id="a5d8044d-74c3-4adf-a3f9-8662762a53c8" class="d-none xref"> <span class="tooltip-container"> <a href="./{41D23FD9-B669-405D-96AF-4B99D8814C55}.html#v29656002"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Malaria is infection with <i>Plasmodium</i> species. Symptoms and signs include fever (which may be periodic), chills, rigors, sweating, diarrhea, abdominal pain, respiratory distress, confusion... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/a/l/malaria-lifecycle-cdc-sized.gif?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v29655979" class="anchor"></span><div class="para"> <p>For recommended drugs and doses for treatment and prevention of malaria, see tables <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"7d93d67f-f973-4622-8b96-c7712ceee420","Title":"Treatment%20of%20Malaria%20in%20the%20United%20States","ShareUrlTitle":"treatment-of-malaria-in-the-united-states","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249483","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ETreatment%20of%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> and <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDrugs%20Used%20to%20Prevent%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>. Common adverse effects and contraindications are listed in table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>. See also the CDC web site (<a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/diagnosis_treatment/index.html">Malaria Diagnosis and Treatment in the United States</a>), or for emergency consultation about management, call the CDC Malaria Hotline at the numbers listed above.</p></div><span id="v1016703" class="anchor"></span><div class="para"> <p>In case of a febrile illness during travel in an endemic region, prompt professional medical evaluation is essential. When prompt evaluation is not possible (eg, because the region is very remote), self-medication with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span> can be considered pending evaluation. If travelers present with fever after returning from an endemic region and no other diagnosis is made, clinicians should consider giving empiric treatment for uncomplicated malaria even when malaria smears and/or rapid diagnostic tests are negative.</p></div> <span id="v1016711"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1016726"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"7d93d67f-f973-4622-8b96-c7712ceee420","Title":"Treatment%20of%20Malaria%20in%20the%20United%20States","ShareUrlTitle":"treatment-of-malaria-in-the-united-states","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56249483","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Treatment%20of%20Malaria%20in%20the%20United%20States","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="7d93d67f-f973-4622-8b96-c7712ceee420"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '7d93d67f-f973-4622-8b96-c7712ceee420' }, async: true, success: function (data) { $('#7d93d67f-f973-4622-8b96-c7712ceee420').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <span id="v55475989"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1017186"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="28959100-f1d1-4fea-9e6e-9f821fc96776"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '28959100-f1d1-4fea-9e6e-9f821fc96776' }, async: true, success: function (data) { $('#28959100-f1d1-4fea-9e6e-9f821fc96776').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <div class="inlinemedia-component " data-ko-rebind="v11730453" data-bind="component: {name: 'inlinemedia-calculator', params: $data}" data-inline-model='{"IframeSrc":"/medical-calculators/QTIntervalCorrection.htm","ImageWidth":null,"ImageHeight":null,"ItemId":"3ecc18fc-1e08-4abe-9722-5bb7a2fc62e9","Title":"QT Interval Correction (EKG)","ShareUrlTitle":"qt-interval-correction-ekg","Description":null,"ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/calculator/icon_calculator_red.png","MediaType":"clinicalcalculator","MediaNameTranslated":"Clinical Calculator","UniqueId":null,"Placement":"sideline","IsInCarousel":false,"Edition":0,"Target":null,"Alt":null}'> </div> <section id="v29656001" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1016697_v29656002" class="topic__header--subsection"> <span itemprop="name" id="v29656002" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v29656005" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/27818359/">Aldámiz-Echevarría LT, López-Polín A, Norman FF, et al</a>: Delayed haemolysis secondary to treatment of severe malaria with intravenous <span class="genericDrug" data-showrollover="false">artesunate</span>: Report on the experience of a referral centre for tropical infections in Spain. <span data-mmanualobjecttype="pubtitle">Travel Med Infect Dis</span> 15:52-56, 2017. doi:10.1016/j.tmaid.2016.10.013</p></div></li><li class="topic__listitem"><span id="v74931460" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/33360105/">Ferreira MU, Nobrega de Sousa T, Rangel GW, et al</a>: Monitoring <i>Plasmodium vivax</i> resistance to antimalarials: persisting challenges and future directions. <i>Int J Parasitol Drug-Drug Resist</i> 15:9-24, 2021. doi:10.1016/j.ijpddr.2020.12.001</p></div></li></ul></div> </div> </section> </div> </section> <section id="v11146950" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Prevention_v11146951" class="topic__header--section"> <span id="v11146951" class="anchor"></span> Prevention of Relapses of <i>P. vivax</i> or <i>P. ovale</i> Malaria </h2> <div class="topic__content"> <span id="v11146954" class="anchor"></span><div class="para"> <p>Hypnozoites must be eliminated from the liver with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> to prevent relapses of <i>P. vivax</i> or <i>P. ovale</i>. <span class="genericDrug" data-showrollover="false">Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> may be given simultaneously with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> or afterward. Some <i>P. vivax</i> strains are less sensitive, and relapse may occur, requiring repeated treatment. <span class="genericDrug" data-showrollover="false">Primaquine</span> is not necessary for <i>P. falciparum</i> or <i>P. malariae</i> because these species do not have a persistent hepatic phase. If exposure to <i>P. vivax</i> or <i>P. ovale</i> is intense or prolonged or if travelers are asplenic, a 14-day prophylactic course of <span class="genericDrug" data-showrollover="false">primaquine</span> or a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> starting when travelers return reduces the risk of recurrence. The main adverse effect is hemolysis in people with glucose-6-phosphate dehydrogenase (G6PD) deficiency. G6PD levels should be determined before <span class="genericDrug" data-showrollover="false">primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is given. </p></div><span id="v11146965" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Primaquine</span> is contraindicated during pregnancy and breastfeeding, unless the infant has been shown not to be G6PD deficient. In pregnant women, chemoprophylaxis with weekly <span class="genericDrug" data-showrollover="false">chloroquine</span> can be given for the remainder of pregnancy, and after delivery, women can be given <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span>, provided they are not G6PD deficient.</p></div> </div> </section> <section id="v1017334" class="topic__section FHead" itemprop="primaryPrevention" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Prevention_v1017335" class="topic__header--section" data-originaltitle="Prevention"> <span id="v1017335" class="anchor"></span> Prevention of Malaria </h2> <div class="topic__content"> <span id="v1017337" class="anchor"></span><div class="para"> <p>Travelers to endemic regions should be given chemoprophylaxis (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDrugs%20Used%20to%20Prevent%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Information about countries where malaria is endemic is available from the Centers for Disease Control and Prevention (CDC) (see <a rel="nofollow" target="_blank" href="https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/yellow-fever-malaria-information-by-country">CDC: Yellow Fever and Malaria Information, by Country</a> and <a rel="nofollow" target="_blank" href="https://www.cdc.gov/malaria/">CDC: Malaria</a>); the information includes types of malaria, resistance patterns, geographic distribution, and recommended prophylaxis.</p></div> <span id="v11147000"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v11147009"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Drugs%20Used%20to%20Prevent%20Malaria","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="dda2e526-a07d-4f4b-8f0e-33540e1f0503"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: 'dda2e526-a07d-4f4b-8f0e-33540e1f0503' }, async: true, success: function (data) { $('#dda2e526-a07d-4f4b-8f0e-33540e1f0503').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v11146968" class="anchor"></span><div class="para"> <p>Malaria during pregnancy poses a serious threat to both mother and fetus. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> can be used during pregnancy in areas where <i>Plasmodium</i> species are susceptible, but there is no other safe and effective prophylactic regimen, so pregnant women should avoid travel to <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant areas whenever possible. Treatment of malaria during pregnancy depends on infecting <i>Plasmodium</i> species and known resistance patterns in the area of acquisition (see <a rel="nofollow" target="_blank" href="https://www.cdc.gov/malaria/diagnosis_treatment/clinicians1.html">CDC: Treatment of Malaria: Guidelines For Clinicians (United States): Alternatives for Pregnant Women</a>).</p></div><span id="v50500132" class="anchor"></span><div class="para"> <p>The safety of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> during pregnancy has not been documented, but limited experience suggests that it may be used when the benefits are judged to outweigh the risks. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> should not be used during pregnancy.</p></div><span id="v11146970" class="anchor"></span><div class="para"> <p>Artemisinins have a short half-life and are not useful for prophylaxis.</p></div><span id="v1017338" class="anchor"></span><div class="para"> <p><b>Prophylactic measures against mosquitoes</b> include </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v11146973" class="anchor"></span><div class="para"> <p>Using <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>permethrin</span>- or pyrethrum-containing residual insecticide sprays (which have prolonged duration of action)</p></div></li><li class="topic__listitem"><span id="v11146975" class="anchor"></span><div class="para"> <p>Placing screens on doors and windows</p></div></li><li class="topic__listitem"><span id="v11146977" class="anchor"></span><div class="para"> <p>Using mosquito netting (preferably impregnated with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>permethrin</span> or pyrethrum) around beds</p></div></li><li class="topic__listitem"><span id="v29656011" class="anchor"></span><div class="para"> <p>Treating clothing and gear (eg, boots, pants, socks, tents) with products containing 0.5% <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>permethrin</span>, which remain protective through several washings (pretreated clothing is available and may protect longer)</p></div></li><li class="topic__listitem"><span id="v11146979" class="anchor"></span><div class="para"> <p>Applying mosquito repellents such as DEET (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>diethyltoluamide</span>) 25 to 35% to exposed skin</p></div></li><li class="topic__listitem"><span id="v11146981" class="anchor"></span><div class="para"> <p>Wearing protective long-sleeved shirts and pants, especially between dusk and dawn, when <i>Anopheles</i> mosquitoes are active</p></div></li></ul></div><span id="v11146983" class="anchor"></span><div class="para"> <p>People who plan to use repellents that contain DEET should be instructed to </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v11146986" class="anchor"></span><div class="para"> <p>Apply repellents only to exposed skin as directed on the label and use them sparingly around ears (they should not be applied to or sprayed in the eyes or mouth).</p></div></li><li class="topic__listitem"><span id="v11146988" class="anchor"></span><div class="para"> <p>Wash hands after application.</p></div></li><li class="topic__listitem"><span id="v11146990" class="anchor"></span><div class="para"> <p>Not allow children to handle repellents (adults should apply the repellent to their hands first, then gently spread it on the child's skin).</p></div></li><li class="topic__listitem"><span id="v11146992" class="anchor"></span><div class="para"> <p>Apply just enough repellent to cover the exposed area.</p></div></li><li class="topic__listitem"><span id="v11146994" class="anchor"></span><div class="para"> <p>Wash the repellant off after returning indoors.</p></div></li><li class="topic__listitem"><span id="v11146996" class="anchor"></span><div class="para"> <p>Wash clothing before wearing again unless indicated otherwise by the product label.</p></div></li></ul></div><span id="v11146997" class="anchor"></span><div class="para"> <p>Most repellents can be used on infants and children < 2 months. The Environmental Protection Agency does not recommend additional precautions for using registered repellents on children or on pregnant or breastfeeding women.</p></div><span id="v11146998" class="anchor"></span><div class="para"> <p>On October 6, 2021, the World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high <i>P. falciparum</i> malaria transmission. (See <a rel="nofollow" target="_blank" href="https://www.who.int/news/item/06-10-2021-who-recommends-groundbreaking-malaria-vaccine-for-children-at-risk">WHO recommends groundbreaking malaria vaccine for children at risk</a>.)</p></div> </div> </section> <section id="v11147157" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v11147159" class="topic__header--section"> <span id="v11147159" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v11147164" class="anchor"></span><div class="para"> <p>In 2020, there were an estimated 241 million people with malaria worldwide, and about 627,000 deaths occurred, mostly in children <span class='symbol'>&lt</span> 5 years in Africa; since 2000, deaths due to malaria have decreased by about 60%.</p></div></li><li class="topic__listitem"><span id="v11147167" class="anchor"></span><div class="para"> <p><i>P. falciparum</i> causes microvascular obstruction and tissue ischemia, particularly in the brain, kidneys, lungs, and gastrointestinal tract of nonimmune infants and adults; patients may die within days of their initial symptoms.</p></div></li><li class="topic__listitem"><span id="v11147171" class="anchor"></span><div class="para"> <p><i>P. vivax</i>, <i>P. ovale</i>, and <i>P. malariae</i> typically do not compromise vital organs; mortality is rare. The full spectrum of malaria occurs with <i>P. knowlesi. </i>Its short asexual replication cycle can result in high parasitemia and severe, potentially fatal disease if untreated.</p></div></li><li class="topic__listitem"><span id="v11147177" class="anchor"></span><div class="para"> <p>Manifestations include recurrent fever and rigor, headache, myalgia, and nausea; hemolytic anemia and splenomegaly are common.</p></div></li><li class="topic__listitem"><span id="v11147180" class="anchor"></span><div class="para"> <p>Diagnose using light microscopy of blood (thin and thick smears) and rapid diagnostic blood tests.</p></div></li><li class="topic__listitem"><span id="v11147182" class="anchor"></span><div class="para"> <p>Treat with antimalarial drugs based on the species (if known) and drug resistance patterns in the area in which infection was acquired. </p></div></li><li class="topic__listitem"><span id="v29656025" class="anchor"></span><div class="para"> <p>Artemisinin-based therapy (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span>, other artemisinin compounds) is the most rapidly active therapy; <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> plus proguanil is an alternative for patients with uncomplicated malaria.</p></div></li><li class="topic__listitem"><span id="v29656027" class="anchor"></span><div class="para"> <p>Use <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> for confirmed or suspected infections with <i>P. vivax</i> and <i>P. ovale</i> to prevent relapse unless patients are pregnant, breastfeeding, have G6PD deficiency, or their G6PD status is unknown.</p></div></li><li class="topic__listitem"><span id="v74931471" class="anchor"></span><div class="para"> <p>Severe malaria requires urgent treatment. Due to the risk of progression to severe disease in patients with <i>P. falciparum</i> infection, patients should be hospitalized to monitor clinical response.</p></div></li><li class="topic__listitem"><span id="v11147185" class="anchor"></span><div class="para"> <p>Give chemoprophylaxis to travelers to endemic areas, and teach them ways to prevent mosquito bites.</p></div></li></ul></div> </div> </section> <section id="v43460806" class="topic__section FHead"> <h2 id="Further_v43460807" class="topic__header--section"> <span id="v43460807" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v74931473" class="anchor"></span><div class="para"> <p>The following English-language resource may be useful. Please note that THE MANUAL is not responsible for the content of this resource.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v43460810" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/malaria">Centers for Disease Control and Prevention (CDC): Resources for Health Professionals: Malaria</a></p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="084">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '084',
 title: 'Malaria',
 itemGuid: '41d23fd9-b669-405d-96af-4b99d8814c55'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{015857DB-A9FE-48A5-BA19-CE776C224748}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Leishmaniasis</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{BAC078E6-5887-4D48-B298-32CEB951B379}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Primary Amebic Meningoencephalitis</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="0a8cc744-7191-471d-90e3-93b721124bd7_mobile" usemap="#0a8cc744-7191-471d-90e3-93b721124bd7_mobile" width="326" height="90">
 <map name="0a8cc744-7191-471d-90e3-93b721124bd7_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="0a8cc744-7191-471d-90e3-93b721124bd7_tablet" usemap="#0a8cc744-7191-471d-90e3-93b721124bd7_tablet" width="326" height="90">
 <map name="0a8cc744-7191-471d-90e3-93b721124bd7_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="0a8cc744-7191-471d-90e3-93b721124bd7_desktop" usemap="#0a8cc744-7191-471d-90e3-93b721124bd7_desktop" width="326" height="90">
 <map name="0a8cc744-7191-471d-90e3-93b721124bd7_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd04
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="41D23FD9B669405D96AF4B99D8814C55">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v55475990'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1017186"></span> <div class="TableFullPage" id="v55475990"> <h3 class="title">Adverse Reactions and Contraindications of Antimalarial Drugs</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476000" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476003" class="anchor"></span><div class="para"> <p>Some Adverse Reactions</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476006" class="anchor"></span><div class="para"> <p>Contraindications</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55476017" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span></p></div></td><td><span id="v55476019" class="anchor"></span><div class="para"> <p>Headache, anorexia, dizziness, asthenia (usually mild)</p></div><span id="v55476020" class="anchor"></span><div class="para"> <p>With lumefantrine, prolonged QT interval</p></div></td><td><span id="v55476022" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span></p></div><span id="v55476023" class="anchor"></span><div class="para"> <p>During pregnancy, used if potential benefit justifies potential risk to fetus, which is usually the case in the 2nd and 3rd trimester and probably the first</p></div><span id="v55476024" class="anchor"></span><div class="para"> <p>Use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> prophylaxis</p></div></td></tr><tr class="even"><td><span id="v55476027" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artesunate</span></p></div></td><td><span id="v55476029" class="anchor"></span><div class="para"> <p>As with artemether</p></div><span id="v55476030" class="anchor"></span><div class="para"> <p>Delayed hemolysis; hemoglobin levels should be monitored for 4 weeks after therapy</p></div></td><td><span id="v55476032" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> </p></div><span id="v55476033" class="anchor"></span><div class="para"> <p>During pregnancy, used if the potential benefit justifies potential risk, which is the case in most patients with severe malaria requiring parenteral therapy</p></div></td></tr><tr class="odd"><td><span id="v55476036" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span></p></div></td><td><span id="v55476038" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headache, dizziness, rash, pruritus</p></div></td><td><span id="v55476040" class="anchor"></span><div class="para"> <p>During pregnancy, used only if there are no alternatives and potential benefit justifies potential risk to fetus</p></div><span id="v55476041" class="anchor"></span><div class="para"> <p>Hypersensitivity, breastfeeding*, severe renal impairment (creatinine clearance <span class='symbol'></span> 30 mL/min)</p></div></td></tr><tr class="even"><td><span id="v55476044" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div><span id="v55476046" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></p></div></td><td><span id="v55476048" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headaches, dizziness, blurred vision, rashes or pruritus, exacerbation of psoriasis, blood dyscrasias, alopecia, ECG changes including prolonged QTc interval, retinopathy, psychosis (rare)</p></div></td><td><span id="v55476050" class="anchor"></span><div class="para"> <p>Hypersensitivity, retinal or visual field changes. or potential drug interactions resulting in prolonged QTc interval and arrhythmia </p></div></td></tr><tr class="odd"><td><span id="v55476053" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span></p></div></td><td><span id="v55476055" class="anchor"></span><div class="para"> <p>Hypotension, bone marrow toxicity, renal dysfunction, rashes, jaundice, tinnitus, <i>Clostridium difficile</i> infection (pseudomembranous colitis)</p></div></td><td><span id="v55476058" class="anchor"></span><div class="para"> <p>Hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476061" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span></p></div></td><td><span id="v55476063" class="anchor"></span><div class="para"> <p>Gastrointestinal upset, photosensitivity, vaginal candidiasis, <i>C. difficile</i> infection (pseudomembranous colitis), erosive esophagitis</p></div></td><td><span id="v55476066" class="anchor"></span><div class="para"> <p>Pregnancy, children < 8></p></div></td></tr><tr class="odd"><td><span id="v55476069" class="anchor"></span><div class="para"> <p>Halofantrine</p></div></td><td><span id="v55476071" class="anchor"></span><div class="para"> <p>Prolongation of PR and QT intervals, cardiac arrhythmia, hypotension, gastrointestinal disturbances, dizziness, mental changes, seizures, sudden death</p></div></td><td><span id="v55476073" class="anchor"></span><div class="para"> <p>During pregnancy, used only if potential benefit justifies potential risk to fetus</p></div><span id="v55476074" class="anchor"></span><div class="para"> <p>Cardiac conduction defects, familial QT prolongation, use of drugs that affect QT interval, hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476077" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span></p></div></td><td><span id="v55476079" class="anchor"></span><div class="para"> <p>Bad dreams, neuropsychiatric symptoms, dizziness, vertigo, confusion, psychosis, seizures, sinus bradycardia, gastrointestinal disturbances</p></div></td><td><span id="v55476081" class="anchor"></span><div class="para"> <p>Hypersensitivity, history of seizures or psychiatric disorders, cardiac conduction disturbances or arrhythmia, coadministration of drugs that may prolong cardiac conduction (eg, beta-blockers, calcium channel blockers, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinidine</span>, halofantrine), occupations that require fine coordination and spatial discrimination and in which vertigo may be life threatening, 1st trimester of pregnancy</p></div></td></tr><tr class="odd"><td><span id="v55476084" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span></p></div></td><td><span id="v55476087" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, tinnitus, visual disturbances, allergic reactions, mental changes, arrhythmias, cardiotoxicity</p></div></td><td><span id="v55476089" class="anchor"></span><div class="para"> <p>Hypersensitivity, G6PD deficiency, optic neuritis, tinnitus, pregnancy (relative contraindication), past adverse <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> reaction (continuous ECG, blood pressure [when drug is given IV], and glucose monitoring recommended)</p></div></td></tr><tr class="even"><td><span id="v55476092" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinidine</span></p></div></td><td><span id="v55476094" class="anchor"></span><div class="para"> <p>Arrhythmias, widened QRS complex, prolonged QTc interval, hypotension, hypoglycemia</p></div></td><td><span id="v55476096" class="anchor"></span><div class="para"> <p>Hypersensitivity, thrombocytopenia (continuous ECG, blood pressure, and glucose monitoring recommended)</p></div><span id="v55476097" class="anchor"></span><div class="para"> <p>No loading dose in patients receiving > 40 mg/kg of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> in the preceding 48 hours or a dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> in preceding 12 hours</p></div></td></tr><tr class="odd"><td><span id="v55476100" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span></p></div></td><td><span id="v55476102" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in people with G6PD deficiency, gastrointestinal disturbances, leukopenia, methemoglobinuria</p></div></td><td><span id="v55476104" class="anchor"></span><div class="para"> <p>Concomitant use of quinacrine or potentially hemolytic or bone marrow suppressing agents, G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown)</p></div></td></tr><tr class="even"><td><span id="v55476107" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Pyrimethamine</span>/sulfadoxine</p></div></td><td><span id="v55476109" class="anchor"></span><div class="para"> <p>Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal neurolysis, urticaria, exfoliative dermatitis, serum sickness, hepatitis, seizures, mental changes, gastrointestinal disturbances, stomatitis, pancreatitis, bone marrow toxicity, hemolysis, fever, nephrosis</p></div></td><td><span id="v55476111" class="anchor"></span><div class="para"> <p>Hypersensitivity, folate deficiency anemia, infants <span class='symbol'>≤</span> 2 months, pregnancy, breastfeeding</p></div></td></tr><tr class="odd"><td><span id="v55476114" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v55476116" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in patients with G6PD deficiency, psychiatric reactions, methemoglobinemia, gastrointestinal disturbances, hypersensitivity reactions</p></div></td><td><span id="v55476118" class="anchor"></span><div class="para"> <p>G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown), breast feeding (unless child is known to have normal G6PD), psychotic disorder, known hypersensitivity</p></div><span id="v55476119" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years </p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v55476010" class="anchor"></span><div class="para"> <p>* Proguanil is excreted in human milk; whether <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> is excreted in human milk is unknown. Safety and effectiveness of these drugs have not been established in children who weigh <span class='symbol'></span> 5 kg.</p></div></td></tr><tr><td colspan="3"><span id="v55476013" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56249347'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1016577"></span> <div class="TableFullPage" id="v56249347"> <h3 class="title">Diagnostic Features of <i>Plasmodium</i> Species in Blood Smears</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><span id="v56249358" class="anchor"></span><div class="para"> <p>Characteristic</p></div></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249361" class="anchor"></span><div class="para"> <p><i>Plasmodium vivax</i>*</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249365" class="anchor"></span><div class="para"> <p><i>Plasmodium falciparum</i></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249369" class="anchor"></span><div class="para"> <p><i>Plasmodium malariae</i>†</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56249394" class="anchor"></span><div class="para"> <p>Infected red blood cells (RBCs) enlarged</p></div></td><td><span id="v56249396" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249398" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249400" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249403" class="anchor"></span><div class="para"> <p>Schüffner dots‡</p></div></td><td><span id="v56249405" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249407" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249409" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249412" class="anchor"></span><div class="para"> <p>Maurer dots or clefts</p></div></td><td><span id="v56249414" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249416" class="anchor"></span><div class="para"> <p>Yes§</p></div></td><td><span id="v56249418" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249421" class="anchor"></span><div class="para"> <p>Multiple infections in RBCs</p></div></td><td><span id="v56249423" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249425" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249427" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249430" class="anchor"></span><div class="para"> <p>Rings with 2 chromatin dots</p></div></td><td><span id="v56249432" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249434" class="anchor"></span><div class="para"> <p>Frequent</p></div></td><td><span id="v56249436" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249439" class="anchor"></span><div class="para"> <p>Crescentic gametocytes</p></div></td><td><span id="v56249441" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249443" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249445" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249448" class="anchor"></span><div class="para"> <p>Bayonet or band trophozoites</p></div></td><td><span id="v56249450" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249452" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249454" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="even"><td><span id="v56249457" class="anchor"></span><div class="para"> <p>Schizonts present in peripheral blood</p></div></td><td><span id="v56249459" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249461" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249463" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="odd"><td><span id="v56249466" class="anchor"></span><div class="para"> <p>Number of merozoites per schizont (mean [range])</p></div></td><td><span id="v56249468" class="anchor"></span><div class="para"> <p>16 (12–24)</p></div></td><td><span id="v56249470" class="anchor"></span><div class="para"> <p>12 (8–24)¶</p></div></td><td><span id="v56249472" class="anchor"></span><div class="para"> <p>8 (6–12)</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56249374" class="anchor"></span><div class="para"> <p>* Red blood cells (RBCs) infected with <i>P. ovale</i> are fimbriated, oval, and slightly enlarged; the parasites otherwise resemble <i>P. vivax</i>.</p></div></td></tr><tr><td colspan="4"><span id="v56249379" class="anchor"></span><div class="para"> <p>† <i>P. knowlesi</i> is morphologically similar to <i>P. malaria</i> and has been confused with it. <i>P. knowlesi </i>should be considered in patients with malaria acquired in Southeast Asia, particularly in Malaysia.</p></div></td></tr><tr><td colspan="4"><span id="v56249384" class="anchor"></span><div class="para"> <p>‡ Schüffner dots are best seen when the blood smear is stained with Giemsa stain.</p></div></td></tr><tr><td colspan="4"><span id="v56249387" class="anchor"></span><div class="para"> <p>§ This feature is not always visible.</p></div></td></tr><tr><td colspan="4"><span id="v56249390" class="anchor"></span><div class="para"> <p>¶ Schizonts are trapped in viscera and usually are not present in peripheral blood.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56250018'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11147009"></span> <div class="TableFullPage" id="v56250018"> <h3 class="title">Drugs Used to Prevent Malaria</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56250029" class="anchor"></span><div class="para"> <p>Drug<sup>a</sup></p></div></th><th style='text-align:left' scope='col'><span id="v56250031" class="anchor"></span><div class="para"> <p>Use</p></div></th><th style='text-align:left' scope='col'><span id="v56250033" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250035" class="anchor"></span><div class="para"> <p>Pediatric Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250037" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56250073" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span><sup>b</sup></p></div></td><td><span id="v56250075" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250077" class="anchor"></span><div class="para"> <p>1 adult tablet once a day</p></div></td><td><span id="v56250079" class="anchor"></span><div class="para"> <p>5–8 kg: one-half pediatric tablet once a day</p></div><span id="v56250080" class="anchor"></span><div class="para"> <p>> 8–10 kg: three-fourths pediatric tablet once a day</p></div><span id="v56250081" class="anchor"></span><div class="para"> <p>> 10–20 kg: 1 pediatric tablet once a day</p></div><span id="v56250082" class="anchor"></span><div class="para"> <p>> 20–30 kg: 2 pediatric tablets once a day</p></div><span id="v56250083" class="anchor"></span><div class="para"> <p>> 30–40 kg: 3 pediatric tablets once a day</p></div><span id="v56250084" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 1 adult tablet once a day</p></div></td><td><span id="v56250086" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after leaving</p></div></td></tr><tr class="even"><td><span id="v56250089" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div></td><td><span id="v56250091" class="anchor"></span><div class="para"> <p>Only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250094" class="anchor"></span><div class="para"> <p>500 mg once a week</p></div></td><td><span id="v56250096" class="anchor"></span><div class="para"> <p>8.3 mg/kg, up to maximum 500 mg once a week</p></div></td><td><span id="v56250098" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued weekly during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250101" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>c</sup></p></div></td><td><span id="v56250103" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250105" class="anchor"></span><div class="para"> <p>100 mg once a day</p></div></td><td><span id="v56250107" class="anchor"></span><div class="para"> <p>≥ 8 years: 2.2 mg/kg (up to 100 mg) once a day</p></div></td><td><span id="v56250109" class="anchor"></span><div class="para"> <p>Begun 1–2 days before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="even"><td><span id="v56250112" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>d</sup></p></div></td><td><span id="v56250114" class="anchor"></span><div class="para"> <p>An alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250117" class="anchor"></span><div class="para"> <p>400 mg once a week</p></div></td><td><span id="v56250119" class="anchor"></span><div class="para"> <p>6.5 mg/kg, up to 400 mg once a week</p></div></td><td><span id="v56250121" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250124" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>e</sup></p></div></td><td><span id="v56250126" class="anchor"></span><div class="para"> <p>In areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250129" class="anchor"></span><div class="para"> <p>250 mg once a week</p></div></td><td><span id="v56250131" class="anchor"></span><div class="para"> <p>≤ 9 kg: 5 mg once a week</p></div><span id="v56250132" class="anchor"></span><div class="para"> <p>> 9–19 kg: one-fourth tablet once a week</p></div><span id="v56250133" class="anchor"></span><div class="para"> <p>> 19–30 kg: one-half tablet once a week</p></div><span id="v56250134" class="anchor"></span><div class="para"> <p>> 30–45 kg: three-fourths tablet once a week</p></div><span id="v56250135" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 45 kg: 1 tablet once a week</p></div></td><td><span id="v56250137" class="anchor"></span><div class="para"> <p>Begun ≥ 2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div><span id="v56250138" class="anchor"></span><div class="para"> <p>Contraindicated in patients with a history of depression, other psychologic problems, or seizures; not recommended for patients with cardiac conduction abnormalities</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250141" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>f</sup></p></div></td><td><span id="v56250143" class="anchor"></span><div class="para"> <p>For primary prophylaxis for brief travel in areas known to harbor mainly <i>P. vivax</i></p></div></td><td><span id="v56250146" class="anchor"></span><div class="para"> <p>52.6 mg once a day</p></div></td><td><span id="v56250148" class="anchor"></span><div class="para"> <p>0.8 mg/kg up to adult dose once a day</p></div></td><td><span id="v56250150" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after departure</p></div><span id="v56250151" class="anchor"></span><div class="para"> <p>Document that the G6PD level is normal before use</p></div><span id="v56250152" class="anchor"></span><div class="para"> <p>Contraindicated in people with G6PD deficiency and in pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level</p></div></td></tr><tr class="odd"><td><span id="v56250155" class="anchor"></span><div class="para"> <p>For terminal prophylaxis to prevent relapse of infection in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel</p></div></td><td><span id="v56250159" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250161" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250163" class="anchor"></span><div class="para"> <p>Given daily for 14 days after departure from endemic area. Document that the G6PD level is normal before use</p></div><span id="v56250164" class="anchor"></span><div class="para"> <p>Contraindications as above</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250167" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v56250169" class="anchor"></span><div class="para"> <p>For primary prophylaxis in travelers to all areas</p></div></td><td><span id="v56250171" class="anchor"></span><div class="para"> <p>200 mg once a day for 3 days before travel as a loading regimen, then 200 mg once weekly for maintenance while in the malaria region starting 7 days after the last loading dose, then a 200 mg final dose after exit 7 days following the last maintenance dose</p></div></td><td><span id="v56250173" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years</p></div></td><td rowspan="2"><span id="v56250175" class="anchor"></span><div class="para"> <p>G6PD deficiency or unknown G6PD status; all patients should be tested for G6PD deficiency prior to use</p></div><span id="v56250176" class="anchor"></span><div class="para"> <p>Pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level; known hypersensitivity</p></div><span id="v56250177" class="anchor"></span><div class="para"> <p>Psychiatric adverse reactions have been observed</p></div><span id="v56250178" class="anchor"></span><div class="para"> <p>Use with caution in patients with a history of psychiatric illness</p></div></td></tr><tr class="odd"><td><span id="v56250181" class="anchor"></span><div class="para"> <p>For terminal prophylaxis in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel </p></div></td><td><span id="v56250185" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56250187" class="anchor"></span><div class="para"> <p>Not for patients < 18=""></p></div></td></tr></tbody> <tfoot><tr><td colspan="5"><span id="v56250041" class="anchor"></span><div class="para"> <p><sup>a </sup>Preventive drugs are given orally. See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications.</p></div></td></tr><tr><td colspan="5"><span id="v56250045" class="anchor"></span><div class="para"> <p><sup>b </sup><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take the drug with food or a milky drink. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is contraindicated in patients with a creatinine clearance < 30="" ml/min.="" this="" combination="" is="" not="" recommended="" for="" children="" weighing="">< 5="" kg="" or="" for="" pregnant="" or="" breastfeeding=""></p></div></td></tr><tr><td colspan="5"><span id="v56250048" class="anchor"></span><div class="para"> <p><sup>c</sup> Use of tetracyclines is contraindicated during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="5"><span id="v56250051" class="anchor"></span><div class="para"> <p><sup>d</sup> Physicians should review the prescribing information for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> before using it.</p></div></td></tr><tr><td colspan="5"><span id="v56250054" class="anchor"></span><div class="para"> <p><sup>e</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> has not been approved for use during pregnancy. The drug is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures; if patients have psychiatric disturbances or a previous history of depression, the drug should be used cautiously. The drug is not recommended for patients with cardiac conduction abnormalities.</p></div></td></tr><tr><td colspan="5"><span id="v56250057" class="anchor"></span><div class="para"> <p><sup>f</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> is used as terminal prophylaxis (radical cure) to reduce risk of relapse in people who have taken <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, or a drug active against <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant malaria as treatment or prophylaxis for prolonged exposure to <i>P. vivax</i> and/or <i>P. ovale</i>. Alternatively, a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can be used in patients who have received <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> for <i>P. vivax</i> treatment or prophylaxis. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> alone can also be used for primary prophylaxis in people at risk of malaria, particularly that due to <i>P. vivax</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> are contraindicated in people with G6PD deficiency and in pregnant or breastfeeding women (unless the breastfed infant has a normal G6PD level).</p></div></td></tr><tr><td colspan="5"><span id="v56250064" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr><tr><td colspan="5"><span id="v56250067" class="anchor"></span><div class="para"> <p>Adapted from the Centers for Disease Control and Prevention <span data-mmanualobjecttype="pubtitle">Yellow Book</span>: <a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria">Infectious diseases related to travel: Malaria</a>. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56249483'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1016726"></span> <div class="TableFullPage" id="v56249483"> <h3 class="title">Treatment of Malaria in the United States</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249495" class="anchor"></span><div class="para"> <p>Preferences</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249498" class="anchor"></span><div class="para"> <p>Drug <sup>a</sup></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249501" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249504" class="anchor"></span><div class="para"> <p>Pediatric Dosage <sup>b</sup></p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249580" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. falciparum</i> or unknown species acquired in all malarious regions. (Additional options for malaria acquired in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive regions listed below.)—Oral drugs</p></div></p></td></tr><tr class="even"><td rowspan="8"><span id="v56249584" class="anchor"></span><div class="para"> <p>Recommended drug</p></div></td><td><span id="v56249586" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249588" class="anchor"></span><div class="para"> <p>6 doses (1 dose <span class='symbol'>=</span> 4 tablets) over 3 days (at 0 and 8 hours), then 1 dose twice a day for the following 2 days</p></div></td><td><span id="v56249590" class="anchor"></span><div class="para"> <p>6 doses at intervals as for the adults; dose <span class='symbol'>=</span></p></div><span id="v56249591" class="anchor"></span><div class="para"> <p><span class='symbol'>5–</span> 15 kg: 1 tablet</p></div><span id="v56249592" class="anchor"></span><div class="para"> <p>15–< 25="" kg:="" 2=""></p></div><span id="v56249593" class="anchor"></span><div class="para"> <p>25–< 35="" kg:="" 3=""></p></div><span id="v56249594" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span> 35 kg: 4 tablets</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249597" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="even"><td><span id="v56249600" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> <sup>d</sup></p></div></td><td><span id="v56249602" class="anchor"></span><div class="para"> <p>4 adult tablets once a day for 3 days</p></div></td><td><span id="v56249604" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 5 kg: Not indicated</p></div><span id="v56249605" class="anchor"></span><div class="para"> <p>5–8 kg: 2 pediatric tablets once a day for 3 days</p></div><span id="v56249606" class="anchor"></span><div class="para"> <p>9–10 kg: 3 pediatric tablets once a day for 3 days</p></div><span id="v56249607" class="anchor"></span><div class="para"> <p>11–20 kg: 1 adult tablet once a day for 3 days</p></div><span id="v56249608" class="anchor"></span><div class="para"> <p>21–30 kg: 2 adult tablets once a day for 3 days</p></div><span id="v56249609" class="anchor"></span><div class="para"> <p>31–40 kg: 3 adult tablets once a day for 3 days</p></div><span id="v56249610" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 4 adult tablets once a day for 3 days</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249613" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="even"><td><span id="v56249616" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> sulfate <b><i>plus one of the following:</i></b></p></div></td><td><span id="v56249618" class="anchor"></span><div class="para"> <p>650 mg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td><td><span id="v56249620" class="anchor"></span><div class="para"> <p>10 mg/kg 3 times a day for 3 or 7 days<sup>e</sup></p></div><span id="v56249621" class="anchor"></span><div class="para"> <p>Dose not to exceed adult dose</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249626" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249628" class="anchor"></span><div class="para"> <p>100 mg twice a day for 7 days</p></div></td><td><span id="v56249630" class="anchor"></span><div class="para"> <p>2.2 mg/kg twice a day for 7 days</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249635" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tetracycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249637" class="anchor"></span><div class="para"> <p>250 mg 4 times a day for 7 days</p></div></td><td><span id="v56249639" class="anchor"></span><div class="para"> <p>6.25 mg/kg 4 times a day for 7 days</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249644" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span> <sup>g</sup></p></div></li></ul></div></td><td><span id="v56249646" class="anchor"></span><div class="para"> <p>7 mg/kg 3 times a day for 7 days</p></div></td><td><span id="v56249648" class="anchor"></span><div class="para"> <p>7 mg/kg 3 times a day for 7 days</p></div></td></tr><tr class="even"><td><span id="v56249651" class="anchor"></span><div class="para"> <p>Alternative (if other options cannot be used)</p></div></td><td><span id="v56249653" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>h</sup></p></div></td><td><span id="v56249655" class="anchor"></span><div class="para"> <p>750 mg once, then 500 mg 6–12 hours later</p></div></td><td><span id="v56249657" class="anchor"></span><div class="para"> <p>15 mg/kg once, then 10 mg /kg 6–12 hours later</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249661" class="anchor"></span><div class="para"> <p>Additional options for uncomplicated malaria due to <i>P. falciparum</i> or unidentified species acquired in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive areas (Central America west of Panama Canal, Haiti, Dominican Republic, most of the Middle East), and <i>P. malariae</i> and <i>P. knowlesi</i> in all regions. If the unidentified species could be <i>P. vivax</i> or <i>P. ovale</i>, terminal treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is given to prevent relapse (see below)—Oral drugs </p></div></p></td></tr><tr class="even"><td rowspan="6"><span id="v56249669" class="anchor"></span><div class="para"> <p>Drugs <sup>i</sup></p></div></td></tr><tr class="odd"><td><span id="v56249672" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> <sup>j,k</sup></p></div></td><td><span id="v56249674" class="anchor"></span><div class="para"> <p>1,000 mg, then 500 mg at 6, 24, and 48 hours</p></div></td><td><span id="v56249676" class="anchor"></span><div class="para"> <p>16.6 mg/kg (up to 1000 mg), then 8.3 mg/kg (up to 500 mg) at 6, 24, and 48 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249679" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249682" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>k</sup></p></div></td><td><span id="v56249684" class="anchor"></span><div class="para"> <p>800 mg, then 400 mg at 6, 24, and 48 hours</p></div></td><td><span id="v56249686" class="anchor"></span><div class="para"> <p>13 mg/kg (up to 800 mg), then 6.5 mg/kg (up to 400 mg) at 6, 24, and 48 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249689" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249692" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249694" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td><td><span id="v56249696" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249700" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. vivax</i> (outside of Papua New Guinea and Indonesia where <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> resistance is prevalent) or <i>P. ovale</i> in all regions—Oral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="5"><span id="v56249705" class="anchor"></span><div class="para"> <p>Recommended drugs <sup>i</sup></p></div></td><td><span id="v56249707" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> <sup>j,k</sup><b><i>or</i></b></p></div><span id="v56249708" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>k</sup></p></div></td><td><span id="v56249710" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249712" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249715" class="anchor"></span><div class="para"> <p style='padding-left:12px'><i><b>plus</b></i></p></div></td></tr><tr class="odd"><td><span id="v56249718" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>l,m</sup></p></div></td><td><span id="v56249720" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days</p></div></td><td><span id="v56249722" class="anchor"></span><div class="para"> <p>0.5 mg/kg (maximum 30 mg) once a day for 14 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249725" class="anchor"></span><div class="para"> <p><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249728" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l,m</sup> </p></div></td><td><span id="v56249730" class="anchor"></span><div class="para"> <p>300 mg single dose</p></div></td><td><span id="v56249732" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years, adult dose</p></div><span id="v56249733" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249737" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. vivax</i> acquired in areas known to harbor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax </i><sup>m</sup> (Papua New Guinea, Indonesia)—Oral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="13"><span id="v56249741" class="anchor"></span><div class="para"> <p>Recommended drugs</p></div></td><td><span id="v56249743" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249745" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td><td><span id="v56249747" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249750" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249753" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> <sup>d</sup></p></div></td><td><span id="v56249755" class="anchor"></span><div class="para"> <p>4 adult tablets once a day for 3 days</p></div></td><td><span id="v56249757" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 5 kg: Not indicated</p></div><span id="v56249758" class="anchor"></span><div class="para"> <p>5–8 kg: 2 pediatric tablets once a day for 3 days</p></div><span id="v56249759" class="anchor"></span><div class="para"> <p>9–10 kg: 3 pediatric tablets once a day for 3 days</p></div><span id="v56249760" class="anchor"></span><div class="para"> <p>11–20 kg: 1 adult tablet once a day for 3 days</p></div><span id="v56249761" class="anchor"></span><div class="para"> <p>21–30 kg: 2 adult tablets once a day for 3 days</p></div><span id="v56249762" class="anchor"></span><div class="para"> <p>31–40 kg: 3 adult tablets once a day for 3 days</p></div><span id="v56249763" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 4 adult tablets once a day for 3 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249766" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249769" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> <b><i>plus one of the following:</i></b></p></div></td><td><span id="v56249771" class="anchor"></span><div class="para"> <p>650 mg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td><td><span id="v56249773" class="anchor"></span><div class="para"> <p>10 mg/kg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249778" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249780" class="anchor"></span><div class="para"> <p>100 mg twice a day for 7 days</p></div></td><td><span id="v56249782" class="anchor"></span><div class="para"> <p>2.2 mg/kg twice a day for 7 days</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249787" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tetracycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249789" class="anchor"></span><div class="para"> <p>250 mg 4 times a day for 7 days</p></div></td><td><span id="v56249791" class="anchor"></span><div class="para"> <p>6.25 mg/kg 4 times a day for 7 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249794" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249797" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>h</sup></p></div></td><td><span id="v56249799" class="anchor"></span><div class="para"> <p>750 mg once, then 500 mg 6–12 hours later</p></div></td><td><span id="v56249801" class="anchor"></span><div class="para"> <p>15 mg/kg once, then 10 mg/kg 6–12 hours later</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249804" class="anchor"></span><div class="para"> <p><b><i>plus, with any of the above regimens</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249807" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>l</sup></p></div></td><td><span id="v56249809" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days</p></div></td><td><span id="v56249811" class="anchor"></span><div class="para"> <p>0.5 mg/kg (maximum 30 mg) once a day for 14 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249814" class="anchor"></span><div class="para"> <p><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249817" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l</sup> </p></div></td><td><span id="v56249819" class="anchor"></span><div class="para"> <p>300 mg single dose</p></div></td><td><span id="v56249821" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years, adult dose</p></div><span id="x000051" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249825" class="anchor"></span><div class="para"> <p>Severe malaria<sup>n</sup>, all <i>Plasmodium</i> —Parenteral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="10"><span id="v56249829" class="anchor"></span><div class="para"> <p>Recommended drugs</p></div></td></tr><tr class="even"><td><span id="v56249832" class="anchor"></span><div class="para"> <p>IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> <sup>n</sup>, commercially available, but if it cannot be obtained within 24 hours, contact the CDC Malaria Hotline <sup>o</sup></p></div><span id="x000114" class="anchor"></span><div class="para"> <p> (If IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> is not immediately available, start interim oral artemether/lumefantine or other alternatives. When <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> arrives, discontinue oral therapy.)</p></div></td><td><span id="v56249834" class="anchor"></span><div class="para"> <p>Adults 2.4 mg/kg actual body weight IV at 0, 12, 24, and 48 hours</p></div></td><td><span id="v56249836" class="anchor"></span><div class="para"> <p>Children < 20="" kg:="" 3="" mg/kg="" actual="" body="" weight="" iv="" at="" 0,="" 12,="" 24,="" and="" 48=""></p></div><span id="v56249837" class="anchor"></span><div class="para"> <p>Children ≥ 20 kg: adult dose</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249840" class="anchor"></span><div class="para"> <p><i>Reassess parasite density 4 or more hours after third dose. When parasite density is <span class='symbol'></span> 1% and patient able to tolerate oral therapy, start oral treatment with one of the following: </i></p></div></td></tr><tr class="even"><td><span id="v56249843" class="anchor"></span><div class="para"> <p>Artemether-lumefantrine (preferred)</p></div></td><td><span id="v56249845" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249847" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="odd"><td><span id="v56249850" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone</span>-proguanil <sup>d</sup></p></div></td><td><span id="v56249852" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249854" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="even"><td><span id="v56249857" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> (age > 8 years and not pregnant) <sup>f</sup></p></div></td><td><span id="v56249859" class="anchor"></span><div class="para"> <p>Dosing as above; same dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> may be given IV if necessary</p></div></td><td><span id="v56249861" class="anchor"></span><div class="para"> <p>Dosing as above; same dose may also be given IV</p></div></td></tr><tr class="odd"><td><span id="v56249864" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span> <sup>g,p</sup> (in children < 8="" years="" and="" pregnant=""></p></div></td><td><span id="v56249866" class="anchor"></span><div class="para"> <p>Oral dosing as above, but if parenteral therapy is required, give 10 mg/kg IV loading dose followed by 5 mg/kg IV every 8 hours</p></div></td><td><span id="v56249868" class="anchor"></span><div class="para"> <p>Oral dosing as above, but if parenteral therapy is required, give 10 mg/kg IV loading dose followed by 5 mg/kg IV every 8 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249871" class="anchor"></span><div class="para"> <p><i><b>plus</b></i>, if <i>P. vivax</i> or <i>P. ovale</i> is likely or confirmed</p></div></td></tr><tr class="odd"><td><span id="v56249876" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span><sup>l</sup></p></div></td><td><span id="v56249878" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days after leaving the endemic area</p></div></td><td><span id="v56249880" class="anchor"></span><div class="para"> <p>0.5 mg/kg once a day (maximum 30 mg) for 14 days after leaving the endemic area</p></div></td></tr><tr class="even"><td><span id="v56249883" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l</sup> </p></div></td><td><span id="v56249885" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56249887" class="anchor"></span><div class="para"> <p>Only for patients ≥ 16 years, use adult dose</p></div><span id="x000052" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56249508" class="anchor"></span><div class="para"> <p><sup>a </sup>See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDrugs%20Used%20to%20Prevent%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications. If malaria has developed during prophylactic drug therapy, that drug should not be used as part of the treatment regimen.</p></div></td></tr><tr><td colspan="4"><span id="v56249512" class="anchor"></span><div class="para"> <p><sup>b</sup> The pediatric dose should not exceed the adult dose.</p></div></td></tr><tr><td colspan="4"><span id="v56249515" class="anchor"></span><div class="para"> <p><sup>c</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> is available as a fixed-dose combination tablet of 20 mg/120 mg. Generally, this combination is not recommended for use in pregnant women, particularly during the 1st trimester, because safety data are insufficient; it may be used if other options are unavailable or are not tolerated and benefits outweigh risks. Patients should take the drug with food or whole milk. If patients vomit within 30 minutes of taking a dose, the dose should be repeated.</p></div></td></tr><tr><td colspan="4"><span id="v56249518" class="anchor"></span><div class="para"> <p><sup>d</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take it with food or a milky drink. This combination is contraindicated in patients with creatinine clearance <span class='symbol'></span> 30 mL/min. Generally, this combination is not recommended for pregnant women, particularly during the 1st trimester, because safety data are insufficient; it may be used if other options are unavailable or are not tolerated and benefits outweigh risks. Twice a day dosing reduces nausea and vomiting as does taking it with food or milk. If patients vomit within 30 min of taking a dose, the dose should be repeated.</p></div></td></tr><tr><td colspan="4"><span id="v56249521" class="anchor"></span><div class="para"> <p><sup>e</sup> In the US, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> sulfate capsules contain 324 mg, so 2 capsules are sufficient for adults. For children, dosing may be more difficult because noncapsule forms of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> are not available. In Southeast Asia, relative resistance to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> has increased, and treatment should be continued for 7 days. In other regions, treatment is continued for only 3 days. To reduce risk of gastrointestinal adverse effects, patients should take <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> with food. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span> is generally preferred to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span> because there is more data on efficacy.</p></div></td></tr><tr><td colspan="4"><span id="v56249524" class="anchor"></span><div class="para"> <p><sup>f</sup> Use of tetracyclines is not recommended during pregnancy and in children <span class='symbol'></span> 8 years. However, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span> may be used if other treatment options are unavailable or not tolerated and if benefit is thought to outweigh risk. </p></div></td></tr><tr><td colspan="4"><span id="v56249527" class="anchor"></span><div class="para"> <p><sup>g</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span> is recommended to be used during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="4"><span id="v56249530" class="anchor"></span><div class="para"> <p><sup>h</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is not recommended unless other options cannot be used because the rate of severe neuropsychiatric reactions is higher with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> than with other options. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is not recommended for infections acquired in Southeast Asia because resistance to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> has been reported in some areas (eg, the Myanmar borders with Thailand, China, and Laos; Thailand-Cambodia border; southern Vietnam).</p></div></td></tr><tr><td colspan="4"><span id="v56249533" class="anchor"></span><div class="para"> <p><sup>i</sup> Any of the drug regimens recommended for <i>P. falciparum</i> malaria in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant areas also can be used for any organism in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive areas; the fastest acting drug for falciparum malaria is artemeter-lumefantrine even if the infecting isolate is <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive. For <i>P. ovale</i> or<i> P. vivax</i> infection, also give <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> (after testing to rule out G6PD deficiency).</p></div></td></tr><tr><td colspan="4"><span id="v56249539" class="anchor"></span><div class="para"> <p><sup>j</sup> To reduce risk of gastrointestinal effects, patients should take <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> with food.</p></div></td></tr><tr><td colspan="4"><span id="v56249542" class="anchor"></span><div class="para"> <p><sup>k</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> is recommended for uncomplicated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive infections; however, regimens used to treat <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant infections may be used if they are more convenient or preferred or if <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> is unavailable.</p></div></td></tr><tr><td colspan="4"><span id="v56249545" class="anchor"></span><div class="para"> <p><sup>l</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> daily for 14 days or a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is used to eradicate <i>P. vivax</i> and <i>P. ovale</i> hypnozoites that may remain dormant in the liver and thus prevent relapses of these infections. Because <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can cause hemolytic anemia in patients with G6PD deficiency, G6PD screening must be done before starting treatment with them. For patients with borderline G6PD deficiency or as an alternate to the above regimen, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> 45 mg orally once a week may be given for 8 weeks; clinicians should consult with an expert in infectious disease and/or tropical medicine if this alternative regimen is being considered for G6PD-deficient patients. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> should not be used during pregnancy, or during breast feeding unless the newborn is tested and has a normal G6PD level.</p></div></td></tr><tr><td colspan="4"><span id="v56249550" class="anchor"></span><div class="para"> <p><sup>m</sup> If patients acquire<i> P. vivax</i> infection in regions not known to harbor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax</i> infection, treatment should start with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>. If they do not respond, treatment should be changed to a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax</i> regimen, and clinicians should call the <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a>.</p></div></td></tr><tr><td colspan="4"><span id="v56249557" class="anchor"></span><div class="para"> <p><sup>n</sup> The CDC recommends that patients with severe malaria be treated with parenteral (IV) <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> as soon as possible. IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinidine</span> is no longer available in the US. Malaria is considered to be severe when patients have ≥ 1 of the following: impaired consciousness, coma or seizure, severe normocyctic anemia (hemoglobin < 7="" g/dl="" [70="" g/l]),="" renal="" failure,="" pulmonary="" edema,="" acute="" respiratory="" distress="" syndrome,="" shock,="" disseminated="" intravascular="" coagulation,="" spontaneous="" bleeding,="" acidosis,="" hemoglobinuria,="" jaundice,="" or="" parasitemia=""> 5%. Severe malaria is most often caused by <i>P. falciparum</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artesunate</span> IV also is recommended for patients who cannot take medications orally.</p></div><span id="v56249559" class="anchor"></span><div class="para"> <p>In the US, IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> received US Food and Drug Administration approval in May 2020. If it cannot be obtained quickly from a commercial source, it is available during an interim period from the CDC by calling the <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a>. It is estimated that it may take 12-24 hours for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> to reach hospitals in the US. </p></div><span id="v56249561" class="anchor"></span><div class="para"> <p>When IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> is not immediately available, start interim oral therapy with artemether-lumefantrine, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>-proguanil, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> sulfate or if nothing else is available, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>. In patients who are vomiting, an antiemetic may be helpful. Those who cannot swallow may be given crushed tablets of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span> through a nasogastric tube.</p></div></td></tr><tr><td colspan="4"><span id="v56249564" class="anchor"></span><div class="para"> <p><sup>o</sup> The <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a> is available at 770-488-7788 or 855-856-4713 toll-free Monday-Friday 9AM to 5PM EST (after hours, weekends, or holidays, 770-488-7100).</p></div></td></tr><tr><td colspan="4"><span id="v56249568" class="anchor"></span><div class="para"> <p><sup>p</sup> If patients cannot take oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span>, a loading dose of 10 mg/kg is given IV, followed by 5 mg/kg every 8 hours, then switched to oral administration as soon as patients are able. Rapid IV administration should be avoided. Treatment course is 7 days.</p></div></td></tr><tr><td colspan="4"><span id="v56249571" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase; CDC = Centers for Disease Control and Prevention</p></div></td></tr><tr><td colspan="4"><span id="v56249574" class="anchor"></span><div class="para"> <p>Adapted from the CDC: <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/diagnosis_treatment/index.html">Malaria diagnosis and treatment in the United States</a>.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56250018'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11147009"></span> <div class="TableFullPage" id="v56250018"> <h3 class="title">Drugs Used to Prevent Malaria</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56250029" class="anchor"></span><div class="para"> <p>Drug<sup>a</sup></p></div></th><th style='text-align:left' scope='col'><span id="v56250031" class="anchor"></span><div class="para"> <p>Use</p></div></th><th style='text-align:left' scope='col'><span id="v56250033" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250035" class="anchor"></span><div class="para"> <p>Pediatric Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250037" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56250073" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span><sup>b</sup></p></div></td><td><span id="v56250075" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250077" class="anchor"></span><div class="para"> <p>1 adult tablet once a day</p></div></td><td><span id="v56250079" class="anchor"></span><div class="para"> <p>5–8 kg: one-half pediatric tablet once a day</p></div><span id="v56250080" class="anchor"></span><div class="para"> <p>> 8–10 kg: three-fourths pediatric tablet once a day</p></div><span id="v56250081" class="anchor"></span><div class="para"> <p>> 10–20 kg: 1 pediatric tablet once a day</p></div><span id="v56250082" class="anchor"></span><div class="para"> <p>> 20–30 kg: 2 pediatric tablets once a day</p></div><span id="v56250083" class="anchor"></span><div class="para"> <p>> 30–40 kg: 3 pediatric tablets once a day</p></div><span id="v56250084" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 1 adult tablet once a day</p></div></td><td><span id="v56250086" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after leaving</p></div></td></tr><tr class="even"><td><span id="v56250089" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div></td><td><span id="v56250091" class="anchor"></span><div class="para"> <p>Only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250094" class="anchor"></span><div class="para"> <p>500 mg once a week</p></div></td><td><span id="v56250096" class="anchor"></span><div class="para"> <p>8.3 mg/kg, up to maximum 500 mg once a week</p></div></td><td><span id="v56250098" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued weekly during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250101" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>c</sup></p></div></td><td><span id="v56250103" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250105" class="anchor"></span><div class="para"> <p>100 mg once a day</p></div></td><td><span id="v56250107" class="anchor"></span><div class="para"> <p>≥ 8 years: 2.2 mg/kg (up to 100 mg) once a day</p></div></td><td><span id="v56250109" class="anchor"></span><div class="para"> <p>Begun 1–2 days before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="even"><td><span id="v56250112" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>d</sup></p></div></td><td><span id="v56250114" class="anchor"></span><div class="para"> <p>An alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250117" class="anchor"></span><div class="para"> <p>400 mg once a week</p></div></td><td><span id="v56250119" class="anchor"></span><div class="para"> <p>6.5 mg/kg, up to 400 mg once a week</p></div></td><td><span id="v56250121" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250124" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>e</sup></p></div></td><td><span id="v56250126" class="anchor"></span><div class="para"> <p>In areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250129" class="anchor"></span><div class="para"> <p>250 mg once a week</p></div></td><td><span id="v56250131" class="anchor"></span><div class="para"> <p>≤ 9 kg: 5 mg once a week</p></div><span id="v56250132" class="anchor"></span><div class="para"> <p>> 9–19 kg: one-fourth tablet once a week</p></div><span id="v56250133" class="anchor"></span><div class="para"> <p>> 19–30 kg: one-half tablet once a week</p></div><span id="v56250134" class="anchor"></span><div class="para"> <p>> 30–45 kg: three-fourths tablet once a week</p></div><span id="v56250135" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 45 kg: 1 tablet once a week</p></div></td><td><span id="v56250137" class="anchor"></span><div class="para"> <p>Begun ≥ 2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div><span id="v56250138" class="anchor"></span><div class="para"> <p>Contraindicated in patients with a history of depression, other psychologic problems, or seizures; not recommended for patients with cardiac conduction abnormalities</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250141" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>f</sup></p></div></td><td><span id="v56250143" class="anchor"></span><div class="para"> <p>For primary prophylaxis for brief travel in areas known to harbor mainly <i>P. vivax</i></p></div></td><td><span id="v56250146" class="anchor"></span><div class="para"> <p>52.6 mg once a day</p></div></td><td><span id="v56250148" class="anchor"></span><div class="para"> <p>0.8 mg/kg up to adult dose once a day</p></div></td><td><span id="v56250150" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after departure</p></div><span id="v56250151" class="anchor"></span><div class="para"> <p>Document that the G6PD level is normal before use</p></div><span id="v56250152" class="anchor"></span><div class="para"> <p>Contraindicated in people with G6PD deficiency and in pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level</p></div></td></tr><tr class="odd"><td><span id="v56250155" class="anchor"></span><div class="para"> <p>For terminal prophylaxis to prevent relapse of infection in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel</p></div></td><td><span id="v56250159" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250161" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250163" class="anchor"></span><div class="para"> <p>Given daily for 14 days after departure from endemic area. Document that the G6PD level is normal before use</p></div><span id="v56250164" class="anchor"></span><div class="para"> <p>Contraindications as above</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250167" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v56250169" class="anchor"></span><div class="para"> <p>For primary prophylaxis in travelers to all areas</p></div></td><td><span id="v56250171" class="anchor"></span><div class="para"> <p>200 mg once a day for 3 days before travel as a loading regimen, then 200 mg once weekly for maintenance while in the malaria region starting 7 days after the last loading dose, then a 200 mg final dose after exit 7 days following the last maintenance dose</p></div></td><td><span id="v56250173" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years</p></div></td><td rowspan="2"><span id="v56250175" class="anchor"></span><div class="para"> <p>G6PD deficiency or unknown G6PD status; all patients should be tested for G6PD deficiency prior to use</p></div><span id="v56250176" class="anchor"></span><div class="para"> <p>Pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level; known hypersensitivity</p></div><span id="v56250177" class="anchor"></span><div class="para"> <p>Psychiatric adverse reactions have been observed</p></div><span id="v56250178" class="anchor"></span><div class="para"> <p>Use with caution in patients with a history of psychiatric illness</p></div></td></tr><tr class="odd"><td><span id="v56250181" class="anchor"></span><div class="para"> <p>For terminal prophylaxis in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel </p></div></td><td><span id="v56250185" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56250187" class="anchor"></span><div class="para"> <p>Not for patients < 18=""></p></div></td></tr></tbody> <tfoot><tr><td colspan="5"><span id="v56250041" class="anchor"></span><div class="para"> <p><sup>a </sup>Preventive drugs are given orally. See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications.</p></div></td></tr><tr><td colspan="5"><span id="v56250045" class="anchor"></span><div class="para"> <p><sup>b </sup><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take the drug with food or a milky drink. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is contraindicated in patients with a creatinine clearance < 30="" ml/min.="" this="" combination="" is="" not="" recommended="" for="" children="" weighing="">< 5="" kg="" or="" for="" pregnant="" or="" breastfeeding=""></p></div></td></tr><tr><td colspan="5"><span id="v56250048" class="anchor"></span><div class="para"> <p><sup>c</sup> Use of tetracyclines is contraindicated during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="5"><span id="v56250051" class="anchor"></span><div class="para"> <p><sup>d</sup> Physicians should review the prescribing information for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> before using it.</p></div></td></tr><tr><td colspan="5"><span id="v56250054" class="anchor"></span><div class="para"> <p><sup>e</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> has not been approved for use during pregnancy. The drug is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures; if patients have psychiatric disturbances or a previous history of depression, the drug should be used cautiously. The drug is not recommended for patients with cardiac conduction abnormalities.</p></div></td></tr><tr><td colspan="5"><span id="v56250057" class="anchor"></span><div class="para"> <p><sup>f</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> is used as terminal prophylaxis (radical cure) to reduce risk of relapse in people who have taken <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, or a drug active against <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant malaria as treatment or prophylaxis for prolonged exposure to <i>P. vivax</i> and/or <i>P. ovale</i>. Alternatively, a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can be used in patients who have received <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> for <i>P. vivax</i> treatment or prophylaxis. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> alone can also be used for primary prophylaxis in people at risk of malaria, particularly that due to <i>P. vivax</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> are contraindicated in people with G6PD deficiency and in pregnant or breastfeeding women (unless the breastfed infant has a normal G6PD level).</p></div></td></tr><tr><td colspan="5"><span id="v56250064" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr><tr><td colspan="5"><span id="v56250067" class="anchor"></span><div class="para"> <p>Adapted from the Centers for Disease Control and Prevention <span data-mmanualobjecttype="pubtitle">Yellow Book</span>: <a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria">Infectious diseases related to travel: Malaria</a>. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56249347'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1016577"></span> <div class="TableFullPage" id="v56249347"> <h3 class="title">Diagnostic Features of <i>Plasmodium</i> Species in Blood Smears</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><span id="v56249358" class="anchor"></span><div class="para"> <p>Characteristic</p></div></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249361" class="anchor"></span><div class="para"> <p><i>Plasmodium vivax</i>*</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249365" class="anchor"></span><div class="para"> <p><i>Plasmodium falciparum</i></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249369" class="anchor"></span><div class="para"> <p><i>Plasmodium malariae</i>†</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56249394" class="anchor"></span><div class="para"> <p>Infected red blood cells (RBCs) enlarged</p></div></td><td><span id="v56249396" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249398" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249400" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249403" class="anchor"></span><div class="para"> <p>Schüffner dots‡</p></div></td><td><span id="v56249405" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249407" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249409" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249412" class="anchor"></span><div class="para"> <p>Maurer dots or clefts</p></div></td><td><span id="v56249414" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249416" class="anchor"></span><div class="para"> <p>Yes§</p></div></td><td><span id="v56249418" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249421" class="anchor"></span><div class="para"> <p>Multiple infections in RBCs</p></div></td><td><span id="v56249423" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249425" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249427" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249430" class="anchor"></span><div class="para"> <p>Rings with 2 chromatin dots</p></div></td><td><span id="v56249432" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249434" class="anchor"></span><div class="para"> <p>Frequent</p></div></td><td><span id="v56249436" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="even"><td><span id="v56249439" class="anchor"></span><div class="para"> <p>Crescentic gametocytes</p></div></td><td><span id="v56249441" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249443" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249445" class="anchor"></span><div class="para"> <p>No</p></div></td></tr><tr class="odd"><td><span id="v56249448" class="anchor"></span><div class="para"> <p>Bayonet or band trophozoites</p></div></td><td><span id="v56249450" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249452" class="anchor"></span><div class="para"> <p>No</p></div></td><td><span id="v56249454" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="even"><td><span id="v56249457" class="anchor"></span><div class="para"> <p>Schizonts present in peripheral blood</p></div></td><td><span id="v56249459" class="anchor"></span><div class="para"> <p>Yes</p></div></td><td><span id="v56249461" class="anchor"></span><div class="para"> <p>Rare</p></div></td><td><span id="v56249463" class="anchor"></span><div class="para"> <p>Yes</p></div></td></tr><tr class="odd"><td><span id="v56249466" class="anchor"></span><div class="para"> <p>Number of merozoites per schizont (mean [range])</p></div></td><td><span id="v56249468" class="anchor"></span><div class="para"> <p>16 (12–24)</p></div></td><td><span id="v56249470" class="anchor"></span><div class="para"> <p>12 (8–24)¶</p></div></td><td><span id="v56249472" class="anchor"></span><div class="para"> <p>8 (6–12)</p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56249374" class="anchor"></span><div class="para"> <p>* Red blood cells (RBCs) infected with <i>P. ovale</i> are fimbriated, oval, and slightly enlarged; the parasites otherwise resemble <i>P. vivax</i>.</p></div></td></tr><tr><td colspan="4"><span id="v56249379" class="anchor"></span><div class="para"> <p>† <i>P. knowlesi</i> is morphologically similar to <i>P. malaria</i> and has been confused with it. <i>P. knowlesi </i>should be considered in patients with malaria acquired in Southeast Asia, particularly in Malaysia.</p></div></td></tr><tr><td colspan="4"><span id="v56249384" class="anchor"></span><div class="para"> <p>‡ Schüffner dots are best seen when the blood smear is stained with Giemsa stain.</p></div></td></tr><tr><td colspan="4"><span id="v56249387" class="anchor"></span><div class="para"> <p>§ This feature is not always visible.</p></div></td></tr><tr><td colspan="4"><span id="v56249390" class="anchor"></span><div class="para"> <p>¶ Schizonts are trapped in viscera and usually are not present in peripheral blood.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56249483'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1016726"></span> <div class="TableFullPage" id="v56249483"> <h3 class="title">Treatment of Malaria in the United States</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249495" class="anchor"></span><div class="para"> <p>Preferences</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249498" class="anchor"></span><div class="para"> <p>Drug <sup>a</sup></p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249501" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56249504" class="anchor"></span><div class="para"> <p>Pediatric Dosage <sup>b</sup></p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249580" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. falciparum</i> or unknown species acquired in all malarious regions. (Additional options for malaria acquired in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive regions listed below.)—Oral drugs</p></div></p></td></tr><tr class="even"><td rowspan="8"><span id="v56249584" class="anchor"></span><div class="para"> <p>Recommended drug</p></div></td><td><span id="v56249586" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249588" class="anchor"></span><div class="para"> <p>6 doses (1 dose <span class='symbol'>=</span> 4 tablets) over 3 days (at 0 and 8 hours), then 1 dose twice a day for the following 2 days</p></div></td><td><span id="v56249590" class="anchor"></span><div class="para"> <p>6 doses at intervals as for the adults; dose <span class='symbol'>=</span></p></div><span id="v56249591" class="anchor"></span><div class="para"> <p><span class='symbol'>5–</span> 15 kg: 1 tablet</p></div><span id="v56249592" class="anchor"></span><div class="para"> <p>15–< 25="" kg:="" 2=""></p></div><span id="v56249593" class="anchor"></span><div class="para"> <p>25–< 35="" kg:="" 3=""></p></div><span id="v56249594" class="anchor"></span><div class="para"> <p><span class='symbol'>≥</span> 35 kg: 4 tablets</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249597" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="even"><td><span id="v56249600" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> <sup>d</sup></p></div></td><td><span id="v56249602" class="anchor"></span><div class="para"> <p>4 adult tablets once a day for 3 days</p></div></td><td><span id="v56249604" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 5 kg: Not indicated</p></div><span id="v56249605" class="anchor"></span><div class="para"> <p>5–8 kg: 2 pediatric tablets once a day for 3 days</p></div><span id="v56249606" class="anchor"></span><div class="para"> <p>9–10 kg: 3 pediatric tablets once a day for 3 days</p></div><span id="v56249607" class="anchor"></span><div class="para"> <p>11–20 kg: 1 adult tablet once a day for 3 days</p></div><span id="v56249608" class="anchor"></span><div class="para"> <p>21–30 kg: 2 adult tablets once a day for 3 days</p></div><span id="v56249609" class="anchor"></span><div class="para"> <p>31–40 kg: 3 adult tablets once a day for 3 days</p></div><span id="v56249610" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 4 adult tablets once a day for 3 days</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249613" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="even"><td><span id="v56249616" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> sulfate <b><i>plus one of the following:</i></b></p></div></td><td><span id="v56249618" class="anchor"></span><div class="para"> <p>650 mg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td><td><span id="v56249620" class="anchor"></span><div class="para"> <p>10 mg/kg 3 times a day for 3 or 7 days<sup>e</sup></p></div><span id="v56249621" class="anchor"></span><div class="para"> <p>Dose not to exceed adult dose</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249626" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249628" class="anchor"></span><div class="para"> <p>100 mg twice a day for 7 days</p></div></td><td><span id="v56249630" class="anchor"></span><div class="para"> <p>2.2 mg/kg twice a day for 7 days</p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249635" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tetracycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249637" class="anchor"></span><div class="para"> <p>250 mg 4 times a day for 7 days</p></div></td><td><span id="v56249639" class="anchor"></span><div class="para"> <p>6.25 mg/kg 4 times a day for 7 days</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249644" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span> <sup>g</sup></p></div></li></ul></div></td><td><span id="v56249646" class="anchor"></span><div class="para"> <p>7 mg/kg 3 times a day for 7 days</p></div></td><td><span id="v56249648" class="anchor"></span><div class="para"> <p>7 mg/kg 3 times a day for 7 days</p></div></td></tr><tr class="even"><td><span id="v56249651" class="anchor"></span><div class="para"> <p>Alternative (if other options cannot be used)</p></div></td><td><span id="v56249653" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>h</sup></p></div></td><td><span id="v56249655" class="anchor"></span><div class="para"> <p>750 mg once, then 500 mg 6–12 hours later</p></div></td><td><span id="v56249657" class="anchor"></span><div class="para"> <p>15 mg/kg once, then 10 mg /kg 6–12 hours later</p></div></td></tr><tr class="odd" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249661" class="anchor"></span><div class="para"> <p>Additional options for uncomplicated malaria due to <i>P. falciparum</i> or unidentified species acquired in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive areas (Central America west of Panama Canal, Haiti, Dominican Republic, most of the Middle East), and <i>P. malariae</i> and <i>P. knowlesi</i> in all regions. If the unidentified species could be <i>P. vivax</i> or <i>P. ovale</i>, terminal treatment with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is given to prevent relapse (see below)—Oral drugs </p></div></p></td></tr><tr class="even"><td rowspan="6"><span id="v56249669" class="anchor"></span><div class="para"> <p>Drugs <sup>i</sup></p></div></td></tr><tr class="odd"><td><span id="v56249672" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> <sup>j,k</sup></p></div></td><td><span id="v56249674" class="anchor"></span><div class="para"> <p>1,000 mg, then 500 mg at 6, 24, and 48 hours</p></div></td><td><span id="v56249676" class="anchor"></span><div class="para"> <p>16.6 mg/kg (up to 1000 mg), then 8.3 mg/kg (up to 500 mg) at 6, 24, and 48 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249679" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249682" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>k</sup></p></div></td><td><span id="v56249684" class="anchor"></span><div class="para"> <p>800 mg, then 400 mg at 6, 24, and 48 hours</p></div></td><td><span id="v56249686" class="anchor"></span><div class="para"> <p>13 mg/kg (up to 800 mg), then 6.5 mg/kg (up to 400 mg) at 6, 24, and 48 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249689" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249692" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249694" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td><td><span id="v56249696" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249700" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. vivax</i> (outside of Papua New Guinea and Indonesia where <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> resistance is prevalent) or <i>P. ovale</i> in all regions—Oral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="5"><span id="v56249705" class="anchor"></span><div class="para"> <p>Recommended drugs <sup>i</sup></p></div></td><td><span id="v56249707" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> <sup>j,k</sup><b><i>or</i></b></p></div><span id="v56249708" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>k</sup></p></div></td><td><span id="v56249710" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249712" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249715" class="anchor"></span><div class="para"> <p style='padding-left:12px'><i><b>plus</b></i></p></div></td></tr><tr class="odd"><td><span id="v56249718" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>l,m</sup></p></div></td><td><span id="v56249720" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days</p></div></td><td><span id="v56249722" class="anchor"></span><div class="para"> <p>0.5 mg/kg (maximum 30 mg) once a day for 14 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249725" class="anchor"></span><div class="para"> <p><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249728" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l,m</sup> </p></div></td><td><span id="v56249730" class="anchor"></span><div class="para"> <p>300 mg single dose</p></div></td><td><span id="v56249732" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years, adult dose</p></div><span id="v56249733" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249737" class="anchor"></span><div class="para"> <p>Uncomplicated malaria due to <i>P. vivax</i> acquired in areas known to harbor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax </i><sup>m</sup> (Papua New Guinea, Indonesia)—Oral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="13"><span id="v56249741" class="anchor"></span><div class="para"> <p>Recommended drugs</p></div></td><td><span id="v56249743" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> <sup>c</sup></p></div></td><td><span id="v56249745" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td><td><span id="v56249747" class="anchor"></span><div class="para"> <p>Dosing above</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249750" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249753" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> <sup>d</sup></p></div></td><td><span id="v56249755" class="anchor"></span><div class="para"> <p>4 adult tablets once a day for 3 days</p></div></td><td><span id="v56249757" class="anchor"></span><div class="para"> <p><span class='symbol'></span> 5 kg: Not indicated</p></div><span id="v56249758" class="anchor"></span><div class="para"> <p>5–8 kg: 2 pediatric tablets once a day for 3 days</p></div><span id="v56249759" class="anchor"></span><div class="para"> <p>9–10 kg: 3 pediatric tablets once a day for 3 days</p></div><span id="v56249760" class="anchor"></span><div class="para"> <p>11–20 kg: 1 adult tablet once a day for 3 days</p></div><span id="v56249761" class="anchor"></span><div class="para"> <p>21–30 kg: 2 adult tablets once a day for 3 days</p></div><span id="v56249762" class="anchor"></span><div class="para"> <p>31–40 kg: 3 adult tablets once a day for 3 days</p></div><span id="v56249763" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 4 adult tablets once a day for 3 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249766" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249769" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> <b><i>plus one of the following:</i></b></p></div></td><td><span id="v56249771" class="anchor"></span><div class="para"> <p>650 mg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td><td><span id="v56249773" class="anchor"></span><div class="para"> <p>10 mg/kg 3 times a day for 3 or 7 days <sup>e</sup></p></div></td></tr><tr class="even"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249778" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249780" class="anchor"></span><div class="para"> <p>100 mg twice a day for 7 days</p></div></td><td><span id="v56249782" class="anchor"></span><div class="para"> <p>2.2 mg/kg twice a day for 7 days</p></div></td></tr><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56249787" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tetracycline</span> <sup>f</sup></p></div></li></ul></div></td><td><span id="v56249789" class="anchor"></span><div class="para"> <p>250 mg 4 times a day for 7 days</p></div></td><td><span id="v56249791" class="anchor"></span><div class="para"> <p>6.25 mg/kg 4 times a day for 7 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249794" class="anchor"></span><div class="para"> <p style='padding-left:12px'><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249797" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>h</sup></p></div></td><td><span id="v56249799" class="anchor"></span><div class="para"> <p>750 mg once, then 500 mg 6–12 hours later</p></div></td><td><span id="v56249801" class="anchor"></span><div class="para"> <p>15 mg/kg once, then 10 mg/kg 6–12 hours later</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249804" class="anchor"></span><div class="para"> <p><b><i>plus, with any of the above regimens</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249807" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>l</sup></p></div></td><td><span id="v56249809" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days</p></div></td><td><span id="v56249811" class="anchor"></span><div class="para"> <p>0.5 mg/kg (maximum 30 mg) once a day for 14 days</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249814" class="anchor"></span><div class="para"> <p><b><i>or</i></b></p></div></td></tr><tr class="odd"><td><span id="v56249817" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l</sup> </p></div></td><td><span id="v56249819" class="anchor"></span><div class="para"> <p>300 mg single dose</p></div></td><td><span id="v56249821" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years, adult dose</p></div><span id="x000051" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr><tr class="even" tablehead2=""><td colspan="4"><p class="tableHead2"><span id="v56249825" class="anchor"></span><div class="para"> <p>Severe malaria<sup>n</sup>, all <i>Plasmodium</i> —Parenteral drugs</p></div></p></td></tr><tr class="odd"><td rowspan="10"><span id="v56249829" class="anchor"></span><div class="para"> <p>Recommended drugs</p></div></td></tr><tr class="even"><td><span id="v56249832" class="anchor"></span><div class="para"> <p>IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> <sup>n</sup>, commercially available, but if it cannot be obtained within 24 hours, contact the CDC Malaria Hotline <sup>o</sup></p></div><span id="x000114" class="anchor"></span><div class="para"> <p> (If IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> is not immediately available, start interim oral artemether/lumefantine or other alternatives. When <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> arrives, discontinue oral therapy.)</p></div></td><td><span id="v56249834" class="anchor"></span><div class="para"> <p>Adults 2.4 mg/kg actual body weight IV at 0, 12, 24, and 48 hours</p></div></td><td><span id="v56249836" class="anchor"></span><div class="para"> <p>Children < 20="" kg:="" 3="" mg/kg="" actual="" body="" weight="" iv="" at="" 0,="" 12,="" 24,="" and="" 48=""></p></div><span id="v56249837" class="anchor"></span><div class="para"> <p>Children ≥ 20 kg: adult dose</p></div></td></tr><tr class="odd"><td colspan="3"><span id="v56249840" class="anchor"></span><div class="para"> <p><i>Reassess parasite density 4 or more hours after third dose. When parasite density is <span class='symbol'></span> 1% and patient able to tolerate oral therapy, start oral treatment with one of the following: </i></p></div></td></tr><tr class="even"><td><span id="v56249843" class="anchor"></span><div class="para"> <p>Artemether-lumefantrine (preferred)</p></div></td><td><span id="v56249845" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249847" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="odd"><td><span id="v56249850" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone</span>-proguanil <sup>d</sup></p></div></td><td><span id="v56249852" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td><td><span id="v56249854" class="anchor"></span><div class="para"> <p>Dosing as above</p></div></td></tr><tr class="even"><td><span id="v56249857" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> (age > 8 years and not pregnant) <sup>f</sup></p></div></td><td><span id="v56249859" class="anchor"></span><div class="para"> <p>Dosing as above; same dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> may be given IV if necessary</p></div></td><td><span id="v56249861" class="anchor"></span><div class="para"> <p>Dosing as above; same dose may also be given IV</p></div></td></tr><tr class="odd"><td><span id="v56249864" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span> <sup>g,p</sup> (in children < 8="" years="" and="" pregnant=""></p></div></td><td><span id="v56249866" class="anchor"></span><div class="para"> <p>Oral dosing as above, but if parenteral therapy is required, give 10 mg/kg IV loading dose followed by 5 mg/kg IV every 8 hours</p></div></td><td><span id="v56249868" class="anchor"></span><div class="para"> <p>Oral dosing as above, but if parenteral therapy is required, give 10 mg/kg IV loading dose followed by 5 mg/kg IV every 8 hours</p></div></td></tr><tr class="even"><td colspan="3"><span id="v56249871" class="anchor"></span><div class="para"> <p><i><b>plus</b></i>, if <i>P. vivax</i> or <i>P. ovale</i> is likely or confirmed</p></div></td></tr><tr class="odd"><td><span id="v56249876" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span><sup>l</sup></p></div></td><td><span id="v56249878" class="anchor"></span><div class="para"> <p>30 mg once a day for 14 days after leaving the endemic area</p></div></td><td><span id="v56249880" class="anchor"></span><div class="para"> <p>0.5 mg/kg once a day (maximum 30 mg) for 14 days after leaving the endemic area</p></div></td></tr><tr class="even"><td><span id="v56249883" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span> <sup>l</sup> </p></div></td><td><span id="v56249885" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56249887" class="anchor"></span><div class="para"> <p>Only for patients ≥ 16 years, use adult dose</p></div><span id="x000052" class="anchor"></span><div class="para"> <p>Only recommended for use with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span></p></div></td></tr></tbody> <tfoot><tr><td colspan="4"><span id="v56249508" class="anchor"></span><div class="para"> <p><sup>a </sup>See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"dda2e526-a07d-4f4b-8f0e-33540e1f0503","Title":"Drugs%20Used%20to%20Prevent%20Malaria","ShareUrlTitle":"drugs-used-to-prevent-malaria","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56250018","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EDrugs%20Used%20to%20Prevent%20Malaria%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications. If malaria has developed during prophylactic drug therapy, that drug should not be used as part of the treatment regimen.</p></div></td></tr><tr><td colspan="4"><span id="v56249512" class="anchor"></span><div class="para"> <p><sup>b</sup> The pediatric dose should not exceed the adult dose.</p></div></td></tr><tr><td colspan="4"><span id="v56249515" class="anchor"></span><div class="para"> <p><sup>c</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span> is available as a fixed-dose combination tablet of 20 mg/120 mg. Generally, this combination is not recommended for use in pregnant women, particularly during the 1st trimester, because safety data are insufficient; it may be used if other options are unavailable or are not tolerated and benefits outweigh risks. Patients should take the drug with food or whole milk. If patients vomit within 30 minutes of taking a dose, the dose should be repeated.</p></div></td></tr><tr><td colspan="4"><span id="v56249518" class="anchor"></span><div class="para"> <p><sup>d</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take it with food or a milky drink. This combination is contraindicated in patients with creatinine clearance <span class='symbol'></span> 30 mL/min. Generally, this combination is not recommended for pregnant women, particularly during the 1st trimester, because safety data are insufficient; it may be used if other options are unavailable or are not tolerated and benefits outweigh risks. Twice a day dosing reduces nausea and vomiting as does taking it with food or milk. If patients vomit within 30 min of taking a dose, the dose should be repeated.</p></div></td></tr><tr><td colspan="4"><span id="v56249521" class="anchor"></span><div class="para"> <p><sup>e</sup> In the US, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> sulfate capsules contain 324 mg, so 2 capsules are sufficient for adults. For children, dosing may be more difficult because noncapsule forms of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> are not available. In Southeast Asia, relative resistance to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> has increased, and treatment should be continued for 7 days. In other regions, treatment is continued for only 3 days. To reduce risk of gastrointestinal adverse effects, patients should take <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> with food. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span> is generally preferred to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span> because there is more data on efficacy.</p></div></td></tr><tr><td colspan="4"><span id="v56249524" class="anchor"></span><div class="para"> <p><sup>f</sup> Use of tetracyclines is not recommended during pregnancy and in children <span class='symbol'></span> 8 years. However, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxycycline</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tetracycline</span> may be used if other treatment options are unavailable or not tolerated and if benefit is thought to outweigh risk. </p></div></td></tr><tr><td colspan="4"><span id="v56249527" class="anchor"></span><div class="para"> <p><sup>g</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span> is recommended to be used during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="4"><span id="v56249530" class="anchor"></span><div class="para"> <p><sup>h</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is not recommended unless other options cannot be used because the rate of severe neuropsychiatric reactions is higher with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> than with other options. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> is not recommended for infections acquired in Southeast Asia because resistance to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> has been reported in some areas (eg, the Myanmar borders with Thailand, China, and Laos; Thailand-Cambodia border; southern Vietnam).</p></div></td></tr><tr><td colspan="4"><span id="v56249533" class="anchor"></span><div class="para"> <p><sup>i</sup> Any of the drug regimens recommended for <i>P. falciparum</i> malaria in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant areas also can be used for any organism in <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive areas; the fastest acting drug for falciparum malaria is artemeter-lumefantrine even if the infecting isolate is <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive. For <i>P. ovale</i> or<i> P. vivax</i> infection, also give <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> (after testing to rule out G6PD deficiency).</p></div></td></tr><tr><td colspan="4"><span id="v56249539" class="anchor"></span><div class="para"> <p><sup>j</sup> To reduce risk of gastrointestinal effects, patients should take <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> with food.</p></div></td></tr><tr><td colspan="4"><span id="v56249542" class="anchor"></span><div class="para"> <p><sup>k</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> is recommended for uncomplicated <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive infections; however, regimens used to treat <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant infections may be used if they are more convenient or preferred or if <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> is unavailable.</p></div></td></tr><tr><td colspan="4"><span id="v56249545" class="anchor"></span><div class="para"> <p><sup>l</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> daily for 14 days or a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> is used to eradicate <i>P. vivax</i> and <i>P. ovale</i> hypnozoites that may remain dormant in the liver and thus prevent relapses of these infections. Because <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can cause hemolytic anemia in patients with G6PD deficiency, G6PD screening must be done before starting treatment with them. For patients with borderline G6PD deficiency or as an alternate to the above regimen, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>primaquine</span> 45 mg orally once a week may be given for 8 weeks; clinicians should consult with an expert in infectious disease and/or tropical medicine if this alternative regimen is being considered for G6PD-deficient patients. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> should not be used during pregnancy, or during breast feeding unless the newborn is tested and has a normal G6PD level.</p></div></td></tr><tr><td colspan="4"><span id="v56249550" class="anchor"></span><div class="para"> <p><sup>m</sup> If patients acquire<i> P. vivax</i> infection in regions not known to harbor <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax</i> infection, treatment should start with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>. If they do not respond, treatment should be changed to a <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-resistant <i>P. vivax</i> regimen, and clinicians should call the <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a>.</p></div></td></tr><tr><td colspan="4"><span id="v56249557" class="anchor"></span><div class="para"> <p><sup>n</sup> The CDC recommends that patients with severe malaria be treated with parenteral (IV) <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> as soon as possible. IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinidine</span> is no longer available in the US. Malaria is considered to be severe when patients have ≥ 1 of the following: impaired consciousness, coma or seizure, severe normocyctic anemia (hemoglobin < 7="" g/dl="" [70="" g/l]),="" renal="" failure,="" pulmonary="" edema,="" acute="" respiratory="" distress="" syndrome,="" shock,="" disseminated="" intravascular="" coagulation,="" spontaneous="" bleeding,="" acidosis,="" hemoglobinuria,="" jaundice,="" or="" parasitemia=""> 5%. Severe malaria is most often caused by <i>P. falciparum</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artesunate</span> IV also is recommended for patients who cannot take medications orally.</p></div><span id="v56249559" class="anchor"></span><div class="para"> <p>In the US, IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> received US Food and Drug Administration approval in May 2020. If it cannot be obtained quickly from a commercial source, it is available during an interim period from the CDC by calling the <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a>. It is estimated that it may take 12-24 hours for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> to reach hospitals in the US. </p></div><span id="v56249561" class="anchor"></span><div class="para"> <p>When IV <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> is not immediately available, start interim oral therapy with artemether-lumefantrine, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>-proguanil, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> sulfate or if nothing else is available, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>. In patients who are vomiting, an antiemetic may be helpful. Those who cannot swallow may be given crushed tablets of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone/proguanil</span> through a nasogastric tube.</p></div></td></tr><tr><td colspan="4"><span id="v56249564" class="anchor"></span><div class="para"> <p><sup>o</sup> The <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/contact_us.html">CDC Malaria Hotline</a> is available at 770-488-7788 or 855-856-4713 toll-free Monday-Friday 9AM to 5PM EST (after hours, weekends, or holidays, 770-488-7100).</p></div></td></tr><tr><td colspan="4"><span id="v56249568" class="anchor"></span><div class="para"> <p><sup>p</sup> If patients cannot take oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>clindamycin</span>, a loading dose of 10 mg/kg is given IV, followed by 5 mg/kg every 8 hours, then switched to oral administration as soon as patients are able. Rapid IV administration should be avoided. Treatment course is 7 days.</p></div></td></tr><tr><td colspan="4"><span id="v56249571" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase; CDC = Centers for Disease Control and Prevention</p></div></td></tr><tr><td colspan="4"><span id="v56249574" class="anchor"></span><div class="para"> <p>Adapted from the CDC: <a rel="nofollow" target="_blank" href="http://www.cdc.gov/malaria/diagnosis_treatment/index.html">Malaria diagnosis and treatment in the United States</a>.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56250018'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11147009"></span> <div class="TableFullPage" id="v56250018"> <h3 class="title">Drugs Used to Prevent Malaria</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56250029" class="anchor"></span><div class="para"> <p>Drug<sup>a</sup></p></div></th><th style='text-align:left' scope='col'><span id="v56250031" class="anchor"></span><div class="para"> <p>Use</p></div></th><th style='text-align:left' scope='col'><span id="v56250033" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250035" class="anchor"></span><div class="para"> <p>Pediatric Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250037" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56250073" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span><sup>b</sup></p></div></td><td><span id="v56250075" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250077" class="anchor"></span><div class="para"> <p>1 adult tablet once a day</p></div></td><td><span id="v56250079" class="anchor"></span><div class="para"> <p>5–8 kg: one-half pediatric tablet once a day</p></div><span id="v56250080" class="anchor"></span><div class="para"> <p>> 8–10 kg: three-fourths pediatric tablet once a day</p></div><span id="v56250081" class="anchor"></span><div class="para"> <p>> 10–20 kg: 1 pediatric tablet once a day</p></div><span id="v56250082" class="anchor"></span><div class="para"> <p>> 20–30 kg: 2 pediatric tablets once a day</p></div><span id="v56250083" class="anchor"></span><div class="para"> <p>> 30–40 kg: 3 pediatric tablets once a day</p></div><span id="v56250084" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 1 adult tablet once a day</p></div></td><td><span id="v56250086" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after leaving</p></div></td></tr><tr class="even"><td><span id="v56250089" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div></td><td><span id="v56250091" class="anchor"></span><div class="para"> <p>Only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250094" class="anchor"></span><div class="para"> <p>500 mg once a week</p></div></td><td><span id="v56250096" class="anchor"></span><div class="para"> <p>8.3 mg/kg, up to maximum 500 mg once a week</p></div></td><td><span id="v56250098" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued weekly during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250101" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>c</sup></p></div></td><td><span id="v56250103" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250105" class="anchor"></span><div class="para"> <p>100 mg once a day</p></div></td><td><span id="v56250107" class="anchor"></span><div class="para"> <p>≥ 8 years: 2.2 mg/kg (up to 100 mg) once a day</p></div></td><td><span id="v56250109" class="anchor"></span><div class="para"> <p>Begun 1–2 days before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="even"><td><span id="v56250112" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>d</sup></p></div></td><td><span id="v56250114" class="anchor"></span><div class="para"> <p>An alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250117" class="anchor"></span><div class="para"> <p>400 mg once a week</p></div></td><td><span id="v56250119" class="anchor"></span><div class="para"> <p>6.5 mg/kg, up to 400 mg once a week</p></div></td><td><span id="v56250121" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250124" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>e</sup></p></div></td><td><span id="v56250126" class="anchor"></span><div class="para"> <p>In areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250129" class="anchor"></span><div class="para"> <p>250 mg once a week</p></div></td><td><span id="v56250131" class="anchor"></span><div class="para"> <p>≤ 9 kg: 5 mg once a week</p></div><span id="v56250132" class="anchor"></span><div class="para"> <p>> 9–19 kg: one-fourth tablet once a week</p></div><span id="v56250133" class="anchor"></span><div class="para"> <p>> 19–30 kg: one-half tablet once a week</p></div><span id="v56250134" class="anchor"></span><div class="para"> <p>> 30–45 kg: three-fourths tablet once a week</p></div><span id="v56250135" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 45 kg: 1 tablet once a week</p></div></td><td><span id="v56250137" class="anchor"></span><div class="para"> <p>Begun ≥ 2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div><span id="v56250138" class="anchor"></span><div class="para"> <p>Contraindicated in patients with a history of depression, other psychologic problems, or seizures; not recommended for patients with cardiac conduction abnormalities</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250141" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>f</sup></p></div></td><td><span id="v56250143" class="anchor"></span><div class="para"> <p>For primary prophylaxis for brief travel in areas known to harbor mainly <i>P. vivax</i></p></div></td><td><span id="v56250146" class="anchor"></span><div class="para"> <p>52.6 mg once a day</p></div></td><td><span id="v56250148" class="anchor"></span><div class="para"> <p>0.8 mg/kg up to adult dose once a day</p></div></td><td><span id="v56250150" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after departure</p></div><span id="v56250151" class="anchor"></span><div class="para"> <p>Document that the G6PD level is normal before use</p></div><span id="v56250152" class="anchor"></span><div class="para"> <p>Contraindicated in people with G6PD deficiency and in pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level</p></div></td></tr><tr class="odd"><td><span id="v56250155" class="anchor"></span><div class="para"> <p>For terminal prophylaxis to prevent relapse of infection in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel</p></div></td><td><span id="v56250159" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250161" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250163" class="anchor"></span><div class="para"> <p>Given daily for 14 days after departure from endemic area. Document that the G6PD level is normal before use</p></div><span id="v56250164" class="anchor"></span><div class="para"> <p>Contraindications as above</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250167" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v56250169" class="anchor"></span><div class="para"> <p>For primary prophylaxis in travelers to all areas</p></div></td><td><span id="v56250171" class="anchor"></span><div class="para"> <p>200 mg once a day for 3 days before travel as a loading regimen, then 200 mg once weekly for maintenance while in the malaria region starting 7 days after the last loading dose, then a 200 mg final dose after exit 7 days following the last maintenance dose</p></div></td><td><span id="v56250173" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years</p></div></td><td rowspan="2"><span id="v56250175" class="anchor"></span><div class="para"> <p>G6PD deficiency or unknown G6PD status; all patients should be tested for G6PD deficiency prior to use</p></div><span id="v56250176" class="anchor"></span><div class="para"> <p>Pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level; known hypersensitivity</p></div><span id="v56250177" class="anchor"></span><div class="para"> <p>Psychiatric adverse reactions have been observed</p></div><span id="v56250178" class="anchor"></span><div class="para"> <p>Use with caution in patients with a history of psychiatric illness</p></div></td></tr><tr class="odd"><td><span id="v56250181" class="anchor"></span><div class="para"> <p>For terminal prophylaxis in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel </p></div></td><td><span id="v56250185" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56250187" class="anchor"></span><div class="para"> <p>Not for patients < 18=""></p></div></td></tr></tbody> <tfoot><tr><td colspan="5"><span id="v56250041" class="anchor"></span><div class="para"> <p><sup>a </sup>Preventive drugs are given orally. See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications.</p></div></td></tr><tr><td colspan="5"><span id="v56250045" class="anchor"></span><div class="para"> <p><sup>b </sup><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take the drug with food or a milky drink. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is contraindicated in patients with a creatinine clearance < 30="" ml/min.="" this="" combination="" is="" not="" recommended="" for="" children="" weighing="">< 5="" kg="" or="" for="" pregnant="" or="" breastfeeding=""></p></div></td></tr><tr><td colspan="5"><span id="v56250048" class="anchor"></span><div class="para"> <p><sup>c</sup> Use of tetracyclines is contraindicated during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="5"><span id="v56250051" class="anchor"></span><div class="para"> <p><sup>d</sup> Physicians should review the prescribing information for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> before using it.</p></div></td></tr><tr><td colspan="5"><span id="v56250054" class="anchor"></span><div class="para"> <p><sup>e</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> has not been approved for use during pregnancy. The drug is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures; if patients have psychiatric disturbances or a previous history of depression, the drug should be used cautiously. The drug is not recommended for patients with cardiac conduction abnormalities.</p></div></td></tr><tr><td colspan="5"><span id="v56250057" class="anchor"></span><div class="para"> <p><sup>f</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> is used as terminal prophylaxis (radical cure) to reduce risk of relapse in people who have taken <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, or a drug active against <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant malaria as treatment or prophylaxis for prolonged exposure to <i>P. vivax</i> and/or <i>P. ovale</i>. Alternatively, a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can be used in patients who have received <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> for <i>P. vivax</i> treatment or prophylaxis. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> alone can also be used for primary prophylaxis in people at risk of malaria, particularly that due to <i>P. vivax</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> are contraindicated in people with G6PD deficiency and in pregnant or breastfeeding women (unless the breastfed infant has a normal G6PD level).</p></div></td></tr><tr><td colspan="5"><span id="v56250064" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr><tr><td colspan="5"><span id="v56250067" class="anchor"></span><div class="para"> <p>Adapted from the Centers for Disease Control and Prevention <span data-mmanualobjecttype="pubtitle">Yellow Book</span>: <a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria">Infectious diseases related to travel: Malaria</a>. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55475990'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1017186"></span> <div class="TableFullPage" id="v55475990"> <h3 class="title">Adverse Reactions and Contraindications of Antimalarial Drugs</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476000" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476003" class="anchor"></span><div class="para"> <p>Some Adverse Reactions</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476006" class="anchor"></span><div class="para"> <p>Contraindications</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55476017" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span></p></div></td><td><span id="v55476019" class="anchor"></span><div class="para"> <p>Headache, anorexia, dizziness, asthenia (usually mild)</p></div><span id="v55476020" class="anchor"></span><div class="para"> <p>With lumefantrine, prolonged QT interval</p></div></td><td><span id="v55476022" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span></p></div><span id="v55476023" class="anchor"></span><div class="para"> <p>During pregnancy, used if potential benefit justifies potential risk to fetus, which is usually the case in the 2nd and 3rd trimester and probably the first</p></div><span id="v55476024" class="anchor"></span><div class="para"> <p>Use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> prophylaxis</p></div></td></tr><tr class="even"><td><span id="v55476027" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artesunate</span></p></div></td><td><span id="v55476029" class="anchor"></span><div class="para"> <p>As with artemether</p></div><span id="v55476030" class="anchor"></span><div class="para"> <p>Delayed hemolysis; hemoglobin levels should be monitored for 4 weeks after therapy</p></div></td><td><span id="v55476032" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> </p></div><span id="v55476033" class="anchor"></span><div class="para"> <p>During pregnancy, used if the potential benefit justifies potential risk, which is the case in most patients with severe malaria requiring parenteral therapy</p></div></td></tr><tr class="odd"><td><span id="v55476036" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span></p></div></td><td><span id="v55476038" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headache, dizziness, rash, pruritus</p></div></td><td><span id="v55476040" class="anchor"></span><div class="para"> <p>During pregnancy, used only if there are no alternatives and potential benefit justifies potential risk to fetus</p></div><span id="v55476041" class="anchor"></span><div class="para"> <p>Hypersensitivity, breastfeeding*, severe renal impairment (creatinine clearance <span class='symbol'></span> 30 mL/min)</p></div></td></tr><tr class="even"><td><span id="v55476044" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div><span id="v55476046" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></p></div></td><td><span id="v55476048" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headaches, dizziness, blurred vision, rashes or pruritus, exacerbation of psoriasis, blood dyscrasias, alopecia, ECG changes including prolonged QTc interval, retinopathy, psychosis (rare)</p></div></td><td><span id="v55476050" class="anchor"></span><div class="para"> <p>Hypersensitivity, retinal or visual field changes. or potential drug interactions resulting in prolonged QTc interval and arrhythmia </p></div></td></tr><tr class="odd"><td><span id="v55476053" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span></p></div></td><td><span id="v55476055" class="anchor"></span><div class="para"> <p>Hypotension, bone marrow toxicity, renal dysfunction, rashes, jaundice, tinnitus, <i>Clostridium difficile</i> infection (pseudomembranous colitis)</p></div></td><td><span id="v55476058" class="anchor"></span><div class="para"> <p>Hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476061" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span></p></div></td><td><span id="v55476063" class="anchor"></span><div class="para"> <p>Gastrointestinal upset, photosensitivity, vaginal candidiasis, <i>C. difficile</i> infection (pseudomembranous colitis), erosive esophagitis</p></div></td><td><span id="v55476066" class="anchor"></span><div class="para"> <p>Pregnancy, children < 8=""></p></div></td></tr><tr class="odd"><td><span id="v55476069" class="anchor"></span><div class="para"> <p>Halofantrine</p></div></td><td><span id="v55476071" class="anchor"></span><div class="para"> <p>Prolongation of PR and QT intervals, cardiac arrhythmia, hypotension, gastrointestinal disturbances, dizziness, mental changes, seizures, sudden death</p></div></td><td><span id="v55476073" class="anchor"></span><div class="para"> <p>During pregnancy, used only if potential benefit justifies potential risk to fetus</p></div><span id="v55476074" class="anchor"></span><div class="para"> <p>Cardiac conduction defects, familial QT prolongation, use of drugs that affect QT interval, hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476077" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span></p></div></td><td><span id="v55476079" class="anchor"></span><div class="para"> <p>Bad dreams, neuropsychiatric symptoms, dizziness, vertigo, confusion, psychosis, seizures, sinus bradycardia, gastrointestinal disturbances</p></div></td><td><span id="v55476081" class="anchor"></span><div class="para"> <p>Hypersensitivity, history of seizures or psychiatric disorders, cardiac conduction disturbances or arrhythmia, coadministration of drugs that may prolong cardiac conduction (eg, beta-blockers, calcium channel blockers, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinidine</span>, halofantrine), occupations that require fine coordination and spatial discrimination and in which vertigo may be life threatening, 1st trimester of pregnancy</p></div></td></tr><tr class="odd"><td><span id="v55476084" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span></p></div></td><td><span id="v55476087" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, tinnitus, visual disturbances, allergic reactions, mental changes, arrhythmias, cardiotoxicity</p></div></td><td><span id="v55476089" class="anchor"></span><div class="para"> <p>Hypersensitivity, G6PD deficiency, optic neuritis, tinnitus, pregnancy (relative contraindication), past adverse <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> reaction (continuous ECG, blood pressure [when drug is given IV], and glucose monitoring recommended)</p></div></td></tr><tr class="even"><td><span id="v55476092" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinidine</span></p></div></td><td><span id="v55476094" class="anchor"></span><div class="para"> <p>Arrhythmias, widened QRS complex, prolonged QTc interval, hypotension, hypoglycemia</p></div></td><td><span id="v55476096" class="anchor"></span><div class="para"> <p>Hypersensitivity, thrombocytopenia (continuous ECG, blood pressure, and glucose monitoring recommended)</p></div><span id="v55476097" class="anchor"></span><div class="para"> <p>No loading dose in patients receiving > 40 mg/kg of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> in the preceding 48 hours or a dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> in preceding 12 hours</p></div></td></tr><tr class="odd"><td><span id="v55476100" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span></p></div></td><td><span id="v55476102" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in people with G6PD deficiency, gastrointestinal disturbances, leukopenia, methemoglobinuria</p></div></td><td><span id="v55476104" class="anchor"></span><div class="para"> <p>Concomitant use of quinacrine or potentially hemolytic or bone marrow suppressing agents, G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown)</p></div></td></tr><tr class="even"><td><span id="v55476107" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Pyrimethamine</span>/sulfadoxine</p></div></td><td><span id="v55476109" class="anchor"></span><div class="para"> <p>Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal neurolysis, urticaria, exfoliative dermatitis, serum sickness, hepatitis, seizures, mental changes, gastrointestinal disturbances, stomatitis, pancreatitis, bone marrow toxicity, hemolysis, fever, nephrosis</p></div></td><td><span id="v55476111" class="anchor"></span><div class="para"> <p>Hypersensitivity, folate deficiency anemia, infants <span class='symbol'>≤</span> 2 months, pregnancy, breastfeeding</p></div></td></tr><tr class="odd"><td><span id="v55476114" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v55476116" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in patients with G6PD deficiency, psychiatric reactions, methemoglobinemia, gastrointestinal disturbances, hypersensitivity reactions</p></div></td><td><span id="v55476118" class="anchor"></span><div class="para"> <p>G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown), breast feeding (unless child is known to have normal G6PD), psychotic disorder, known hypersensitivity</p></div><span id="v55476119" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years </p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v55476010" class="anchor"></span><div class="para"> <p>* Proguanil is excreted in human milk; whether <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> is excreted in human milk is unknown. Safety and effectiveness of these drugs have not been established in children who weigh <span class='symbol'></span> 5 kg.</p></div></td></tr><tr><td colspan="3"><span id="v55476013" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56250018'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11147009"></span> <div class="TableFullPage" id="v56250018"> <h3 class="title">Drugs Used to Prevent Malaria</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56250029" class="anchor"></span><div class="para"> <p>Drug<sup>a</sup></p></div></th><th style='text-align:left' scope='col'><span id="v56250031" class="anchor"></span><div class="para"> <p>Use</p></div></th><th style='text-align:left' scope='col'><span id="v56250033" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250035" class="anchor"></span><div class="para"> <p>Pediatric Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250037" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56250073" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span><sup>b</sup></p></div></td><td><span id="v56250075" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250077" class="anchor"></span><div class="para"> <p>1 adult tablet once a day</p></div></td><td><span id="v56250079" class="anchor"></span><div class="para"> <p>5–8 kg: one-half pediatric tablet once a day</p></div><span id="v56250080" class="anchor"></span><div class="para"> <p>> 8–10 kg: three-fourths pediatric tablet once a day</p></div><span id="v56250081" class="anchor"></span><div class="para"> <p>> 10–20 kg: 1 pediatric tablet once a day</p></div><span id="v56250082" class="anchor"></span><div class="para"> <p>> 20–30 kg: 2 pediatric tablets once a day</p></div><span id="v56250083" class="anchor"></span><div class="para"> <p>> 30–40 kg: 3 pediatric tablets once a day</p></div><span id="v56250084" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 1 adult tablet once a day</p></div></td><td><span id="v56250086" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after leaving</p></div></td></tr><tr class="even"><td><span id="v56250089" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div></td><td><span id="v56250091" class="anchor"></span><div class="para"> <p>Only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250094" class="anchor"></span><div class="para"> <p>500 mg once a week</p></div></td><td><span id="v56250096" class="anchor"></span><div class="para"> <p>8.3 mg/kg, up to maximum 500 mg once a week</p></div></td><td><span id="v56250098" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued weekly during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250101" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>c</sup></p></div></td><td><span id="v56250103" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250105" class="anchor"></span><div class="para"> <p>100 mg once a day</p></div></td><td><span id="v56250107" class="anchor"></span><div class="para"> <p>≥ 8 years: 2.2 mg/kg (up to 100 mg) once a day</p></div></td><td><span id="v56250109" class="anchor"></span><div class="para"> <p>Begun 1–2 days before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="even"><td><span id="v56250112" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>d</sup></p></div></td><td><span id="v56250114" class="anchor"></span><div class="para"> <p>An alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250117" class="anchor"></span><div class="para"> <p>400 mg once a week</p></div></td><td><span id="v56250119" class="anchor"></span><div class="para"> <p>6.5 mg/kg, up to 400 mg once a week</p></div></td><td><span id="v56250121" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250124" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>e</sup></p></div></td><td><span id="v56250126" class="anchor"></span><div class="para"> <p>In areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250129" class="anchor"></span><div class="para"> <p>250 mg once a week</p></div></td><td><span id="v56250131" class="anchor"></span><div class="para"> <p>≤ 9 kg: 5 mg once a week</p></div><span id="v56250132" class="anchor"></span><div class="para"> <p>> 9–19 kg: one-fourth tablet once a week</p></div><span id="v56250133" class="anchor"></span><div class="para"> <p>> 19–30 kg: one-half tablet once a week</p></div><span id="v56250134" class="anchor"></span><div class="para"> <p>> 30–45 kg: three-fourths tablet once a week</p></div><span id="v56250135" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 45 kg: 1 tablet once a week</p></div></td><td><span id="v56250137" class="anchor"></span><div class="para"> <p>Begun ≥ 2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div><span id="v56250138" class="anchor"></span><div class="para"> <p>Contraindicated in patients with a history of depression, other psychologic problems, or seizures; not recommended for patients with cardiac conduction abnormalities</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250141" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>f</sup></p></div></td><td><span id="v56250143" class="anchor"></span><div class="para"> <p>For primary prophylaxis for brief travel in areas known to harbor mainly <i>P. vivax</i></p></div></td><td><span id="v56250146" class="anchor"></span><div class="para"> <p>52.6 mg once a day</p></div></td><td><span id="v56250148" class="anchor"></span><div class="para"> <p>0.8 mg/kg up to adult dose once a day</p></div></td><td><span id="v56250150" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after departure</p></div><span id="v56250151" class="anchor"></span><div class="para"> <p>Document that the G6PD level is normal before use</p></div><span id="v56250152" class="anchor"></span><div class="para"> <p>Contraindicated in people with G6PD deficiency and in pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level</p></div></td></tr><tr class="odd"><td><span id="v56250155" class="anchor"></span><div class="para"> <p>For terminal prophylaxis to prevent relapse of infection in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel</p></div></td><td><span id="v56250159" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250161" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250163" class="anchor"></span><div class="para"> <p>Given daily for 14 days after departure from endemic area. Document that the G6PD level is normal before use</p></div><span id="v56250164" class="anchor"></span><div class="para"> <p>Contraindications as above</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250167" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v56250169" class="anchor"></span><div class="para"> <p>For primary prophylaxis in travelers to all areas</p></div></td><td><span id="v56250171" class="anchor"></span><div class="para"> <p>200 mg once a day for 3 days before travel as a loading regimen, then 200 mg once weekly for maintenance while in the malaria region starting 7 days after the last loading dose, then a 200 mg final dose after exit 7 days following the last maintenance dose</p></div></td><td><span id="v56250173" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years</p></div></td><td rowspan="2"><span id="v56250175" class="anchor"></span><div class="para"> <p>G6PD deficiency or unknown G6PD status; all patients should be tested for G6PD deficiency prior to use</p></div><span id="v56250176" class="anchor"></span><div class="para"> <p>Pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level; known hypersensitivity</p></div><span id="v56250177" class="anchor"></span><div class="para"> <p>Psychiatric adverse reactions have been observed</p></div><span id="v56250178" class="anchor"></span><div class="para"> <p>Use with caution in patients with a history of psychiatric illness</p></div></td></tr><tr class="odd"><td><span id="v56250181" class="anchor"></span><div class="para"> <p>For terminal prophylaxis in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel </p></div></td><td><span id="v56250185" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56250187" class="anchor"></span><div class="para"> <p>Not for patients < 18=""></p></div></td></tr></tbody> <tfoot><tr><td colspan="5"><span id="v56250041" class="anchor"></span><div class="para"> <p><sup>a </sup>Preventive drugs are given orally. See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications.</p></div></td></tr><tr><td colspan="5"><span id="v56250045" class="anchor"></span><div class="para"> <p><sup>b </sup><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take the drug with food or a milky drink. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is contraindicated in patients with a creatinine clearance < 30="" ml/min.="" this="" combination="" is="" not="" recommended="" for="" children="" weighing="">< 5="" kg="" or="" for="" pregnant="" or="" breastfeeding=""></p></div></td></tr><tr><td colspan="5"><span id="v56250048" class="anchor"></span><div class="para"> <p><sup>c</sup> Use of tetracyclines is contraindicated during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="5"><span id="v56250051" class="anchor"></span><div class="para"> <p><sup>d</sup> Physicians should review the prescribing information for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> before using it.</p></div></td></tr><tr><td colspan="5"><span id="v56250054" class="anchor"></span><div class="para"> <p><sup>e</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> has not been approved for use during pregnancy. The drug is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures; if patients have psychiatric disturbances or a previous history of depression, the drug should be used cautiously. The drug is not recommended for patients with cardiac conduction abnormalities.</p></div></td></tr><tr><td colspan="5"><span id="v56250057" class="anchor"></span><div class="para"> <p><sup>f</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> is used as terminal prophylaxis (radical cure) to reduce risk of relapse in people who have taken <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, or a drug active against <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant malaria as treatment or prophylaxis for prolonged exposure to <i>P. vivax</i> and/or <i>P. ovale</i>. Alternatively, a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can be used in patients who have received <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> for <i>P. vivax</i> treatment or prophylaxis. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> alone can also be used for primary prophylaxis in people at risk of malaria, particularly that due to <i>P. vivax</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> are contraindicated in people with G6PD deficiency and in pregnant or breastfeeding women (unless the breastfed infant has a normal G6PD level).</p></div></td></tr><tr><td colspan="5"><span id="v56250064" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr><tr><td colspan="5"><span id="v56250067" class="anchor"></span><div class="para"> <p>Adapted from the Centers for Disease Control and Prevention <span data-mmanualobjecttype="pubtitle">Yellow Book</span>: <a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria">Infectious diseases related to travel: Malaria</a>. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v55475990'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1017186"></span> <div class="TableFullPage" id="v55475990"> <h3 class="title">Adverse Reactions and Contraindications of Antimalarial Drugs</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476000" class="anchor"></span><div class="para"> <p>Drug</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476003" class="anchor"></span><div class="para"> <p>Some Adverse Reactions</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v55476006" class="anchor"></span><div class="para"> <p>Contraindications</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v55476017" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artemether/lumefantrine</span></p></div></td><td><span id="v55476019" class="anchor"></span><div class="para"> <p>Headache, anorexia, dizziness, asthenia (usually mild)</p></div><span id="v55476020" class="anchor"></span><div class="para"> <p>With lumefantrine, prolonged QT interval</p></div></td><td><span id="v55476022" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artemether/lumefantrine</span></p></div><span id="v55476023" class="anchor"></span><div class="para"> <p>During pregnancy, used if potential benefit justifies potential risk to fetus, which is usually the case in the 2nd and 3rd trimester and probably the first</p></div><span id="v55476024" class="anchor"></span><div class="para"> <p>Use of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> prophylaxis</p></div></td></tr><tr class="even"><td><span id="v55476027" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Artesunate</span></p></div></td><td><span id="v55476029" class="anchor"></span><div class="para"> <p>As with artemether</p></div><span id="v55476030" class="anchor"></span><div class="para"> <p>Delayed hemolysis; hemoglobin levels should be monitored for 4 weeks after therapy</p></div></td><td><span id="v55476032" class="anchor"></span><div class="para"> <p>Allergy to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>artesunate</span> </p></div><span id="v55476033" class="anchor"></span><div class="para"> <p>During pregnancy, used if the potential benefit justifies potential risk, which is the case in most patients with severe malaria requiring parenteral therapy</p></div></td></tr><tr class="odd"><td><span id="v55476036" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span></p></div></td><td><span id="v55476038" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headache, dizziness, rash, pruritus</p></div></td><td><span id="v55476040" class="anchor"></span><div class="para"> <p>During pregnancy, used only if there are no alternatives and potential benefit justifies potential risk to fetus</p></div><span id="v55476041" class="anchor"></span><div class="para"> <p>Hypersensitivity, breastfeeding*, severe renal impairment (creatinine clearance <span class='symbol'></span> 30 mL/min)</p></div></td></tr><tr class="even"><td><span id="v55476044" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div><span id="v55476046" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span></p></div></td><td><span id="v55476048" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, headaches, dizziness, blurred vision, rashes or pruritus, exacerbation of psoriasis, blood dyscrasias, alopecia, ECG changes including prolonged QTc interval, retinopathy, psychosis (rare)</p></div></td><td><span id="v55476050" class="anchor"></span><div class="para"> <p>Hypersensitivity, retinal or visual field changes. or potential drug interactions resulting in prolonged QTc interval and arrhythmia </p></div></td></tr><tr class="odd"><td><span id="v55476053" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Clindamycin</span></p></div></td><td><span id="v55476055" class="anchor"></span><div class="para"> <p>Hypotension, bone marrow toxicity, renal dysfunction, rashes, jaundice, tinnitus, <i>Clostridium difficile</i> infection (pseudomembranous colitis)</p></div></td><td><span id="v55476058" class="anchor"></span><div class="para"> <p>Hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476061" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span></p></div></td><td><span id="v55476063" class="anchor"></span><div class="para"> <p>Gastrointestinal upset, photosensitivity, vaginal candidiasis, <i>C. difficile</i> infection (pseudomembranous colitis), erosive esophagitis</p></div></td><td><span id="v55476066" class="anchor"></span><div class="para"> <p>Pregnancy, children < 8=""></p></div></td></tr><tr class="odd"><td><span id="v55476069" class="anchor"></span><div class="para"> <p>Halofantrine</p></div></td><td><span id="v55476071" class="anchor"></span><div class="para"> <p>Prolongation of PR and QT intervals, cardiac arrhythmia, hypotension, gastrointestinal disturbances, dizziness, mental changes, seizures, sudden death</p></div></td><td><span id="v55476073" class="anchor"></span><div class="para"> <p>During pregnancy, used only if potential benefit justifies potential risk to fetus</p></div><span id="v55476074" class="anchor"></span><div class="para"> <p>Cardiac conduction defects, familial QT prolongation, use of drugs that affect QT interval, hypersensitivity</p></div></td></tr><tr class="even"><td><span id="v55476077" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span></p></div></td><td><span id="v55476079" class="anchor"></span><div class="para"> <p>Bad dreams, neuropsychiatric symptoms, dizziness, vertigo, confusion, psychosis, seizures, sinus bradycardia, gastrointestinal disturbances</p></div></td><td><span id="v55476081" class="anchor"></span><div class="para"> <p>Hypersensitivity, history of seizures or psychiatric disorders, cardiac conduction disturbances or arrhythmia, coadministration of drugs that may prolong cardiac conduction (eg, beta-blockers, calcium channel blockers, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinidine</span>, halofantrine), occupations that require fine coordination and spatial discrimination and in which vertigo may be life threatening, 1st trimester of pregnancy</p></div></td></tr><tr class="odd"><td><span id="v55476084" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinine</span></p></div></td><td><span id="v55476087" class="anchor"></span><div class="para"> <p>Gastrointestinal disturbances, tinnitus, visual disturbances, allergic reactions, mental changes, arrhythmias, cardiotoxicity</p></div></td><td><span id="v55476089" class="anchor"></span><div class="para"> <p>Hypersensitivity, G6PD deficiency, optic neuritis, tinnitus, pregnancy (relative contraindication), past adverse <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> reaction (continuous ECG, blood pressure [when drug is given IV], and glucose monitoring recommended)</p></div></td></tr><tr class="even"><td><span id="v55476092" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Quinidine</span></p></div></td><td><span id="v55476094" class="anchor"></span><div class="para"> <p>Arrhythmias, widened QRS complex, prolonged QTc interval, hypotension, hypoglycemia</p></div></td><td><span id="v55476096" class="anchor"></span><div class="para"> <p>Hypersensitivity, thrombocytopenia (continuous ECG, blood pressure, and glucose monitoring recommended)</p></div><span id="v55476097" class="anchor"></span><div class="para"> <p>No loading dose in patients receiving > 40 mg/kg of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>quinine</span> in the preceding 48 hours or a dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span> in preceding 12 hours</p></div></td></tr><tr class="odd"><td><span id="v55476100" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span></p></div></td><td><span id="v55476102" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in people with G6PD deficiency, gastrointestinal disturbances, leukopenia, methemoglobinuria</p></div></td><td><span id="v55476104" class="anchor"></span><div class="para"> <p>Concomitant use of quinacrine or potentially hemolytic or bone marrow suppressing agents, G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown)</p></div></td></tr><tr class="even"><td><span id="v55476107" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Pyrimethamine</span>/sulfadoxine</p></div></td><td><span id="v55476109" class="anchor"></span><div class="para"> <p>Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal neurolysis, urticaria, exfoliative dermatitis, serum sickness, hepatitis, seizures, mental changes, gastrointestinal disturbances, stomatitis, pancreatitis, bone marrow toxicity, hemolysis, fever, nephrosis</p></div></td><td><span id="v55476111" class="anchor"></span><div class="para"> <p>Hypersensitivity, folate deficiency anemia, infants <span class='symbol'>≤</span> 2 months, pregnancy, breastfeeding</p></div></td></tr><tr class="odd"><td><span id="v55476114" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v55476116" class="anchor"></span><div class="para"> <p>Severe intravascular hemolysis in patients with G6PD deficiency, psychiatric reactions, methemoglobinemia, gastrointestinal disturbances, hypersensitivity reactions</p></div></td><td><span id="v55476118" class="anchor"></span><div class="para"> <p>G6PD deficiency, pregnancy (because G6PD status of the fetus is unknown), breast feeding (unless child is known to have normal G6PD), psychotic disorder, known hypersensitivity</p></div><span id="v55476119" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years </p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v55476010" class="anchor"></span><div class="para"> <p>* Proguanil is excreted in human milk; whether <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span> is excreted in human milk is unknown. Safety and effectiveness of these drugs have not been established in children who weigh <span class='symbol'></span> 5 kg.</p></div></td></tr><tr><td colspan="3"><span id="v55476013" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56250018'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v11147009"></span> <div class="TableFullPage" id="v56250018"> <h3 class="title">Drugs Used to Prevent Malaria</h3> <div class="tableWrapper"> <table> <thead><tr><th style='text-align:left' scope='col'><span id="v56250029" class="anchor"></span><div class="para"> <p>Drug<sup>a</sup></p></div></th><th style='text-align:left' scope='col'><span id="v56250031" class="anchor"></span><div class="para"> <p>Use</p></div></th><th style='text-align:left' scope='col'><span id="v56250033" class="anchor"></span><div class="para"> <p>Adult Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250035" class="anchor"></span><div class="para"> <p>Pediatric Dosage</p></div></th><th style='text-align:left' scope='col'><span id="v56250037" class="anchor"></span><div class="para"> <p>Comments</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56250073" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span><sup>b</sup></p></div></td><td><span id="v56250075" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250077" class="anchor"></span><div class="para"> <p>1 adult tablet once a day</p></div></td><td><span id="v56250079" class="anchor"></span><div class="para"> <p>5–8 kg: one-half pediatric tablet once a day</p></div><span id="v56250080" class="anchor"></span><div class="para"> <p>> 8–10 kg: three-fourths pediatric tablet once a day</p></div><span id="v56250081" class="anchor"></span><div class="para"> <p>> 10–20 kg: 1 pediatric tablet once a day</p></div><span id="v56250082" class="anchor"></span><div class="para"> <p>> 20–30 kg: 2 pediatric tablets once a day</p></div><span id="v56250083" class="anchor"></span><div class="para"> <p>> 30–40 kg: 3 pediatric tablets once a day</p></div><span id="v56250084" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 40 kg: 1 adult tablet once a day</p></div></td><td><span id="v56250086" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after leaving</p></div></td></tr><tr class="even"><td><span id="v56250089" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Chloroquine</span></p></div></td><td><span id="v56250091" class="anchor"></span><div class="para"> <p>Only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250094" class="anchor"></span><div class="para"> <p>500 mg once a week</p></div></td><td><span id="v56250096" class="anchor"></span><div class="para"> <p>8.3 mg/kg, up to maximum 500 mg once a week</p></div></td><td><span id="v56250098" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued weekly during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250101" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Doxycycline</span> <sup>c</sup></p></div></td><td><span id="v56250103" class="anchor"></span><div class="para"> <p>In all areas</p></div></td><td><span id="v56250105" class="anchor"></span><div class="para"> <p>100 mg once a day</p></div></td><td><span id="v56250107" class="anchor"></span><div class="para"> <p>≥ 8 years: 2.2 mg/kg (up to 100 mg) once a day</p></div></td><td><span id="v56250109" class="anchor"></span><div class="para"> <p>Begun 1–2 days before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="even"><td><span id="v56250112" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Hydroxychloroquine</span> <sup>d</sup></p></div></td><td><span id="v56250114" class="anchor"></span><div class="para"> <p>An alternative to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> only in areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250117" class="anchor"></span><div class="para"> <p>400 mg once a week</p></div></td><td><span id="v56250119" class="anchor"></span><div class="para"> <p>6.5 mg/kg, up to 400 mg once a week</p></div></td><td><span id="v56250121" class="anchor"></span><div class="para"> <p>Begun 1–2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div></td></tr><tr class="odd"><td><span id="v56250124" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> <sup>e</sup></p></div></td><td><span id="v56250126" class="anchor"></span><div class="para"> <p>In areas with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>mefloquine</span>-sensitive <i>Plasmodium</i></p></div></td><td><span id="v56250129" class="anchor"></span><div class="para"> <p>250 mg once a week</p></div></td><td><span id="v56250131" class="anchor"></span><div class="para"> <p>≤ 9 kg: 5 mg once a week</p></div><span id="v56250132" class="anchor"></span><div class="para"> <p>> 9–19 kg: one-fourth tablet once a week</p></div><span id="v56250133" class="anchor"></span><div class="para"> <p>> 19–30 kg: one-half tablet once a week</p></div><span id="v56250134" class="anchor"></span><div class="para"> <p>> 30–45 kg: three-fourths tablet once a week</p></div><span id="v56250135" class="anchor"></span><div class="para"> <p><span class='symbol'>></span> 45 kg: 1 tablet once a week</p></div></td><td><span id="v56250137" class="anchor"></span><div class="para"> <p>Begun ≥ 2 weeks before travel and continued during the stay and for 4 weeks after leaving</p></div><span id="v56250138" class="anchor"></span><div class="para"> <p>Contraindicated in patients with a history of depression, other psychologic problems, or seizures; not recommended for patients with cardiac conduction abnormalities</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250141" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> <sup>f</sup></p></div></td><td><span id="v56250143" class="anchor"></span><div class="para"> <p>For primary prophylaxis for brief travel in areas known to harbor mainly <i>P. vivax</i></p></div></td><td><span id="v56250146" class="anchor"></span><div class="para"> <p>52.6 mg once a day</p></div></td><td><span id="v56250148" class="anchor"></span><div class="para"> <p>0.8 mg/kg up to adult dose once a day</p></div></td><td><span id="v56250150" class="anchor"></span><div class="para"> <p>Begun 1 to 2 days before travel and continued daily during the stay and for 7 days after departure</p></div><span id="v56250151" class="anchor"></span><div class="para"> <p>Document that the G6PD level is normal before use</p></div><span id="v56250152" class="anchor"></span><div class="para"> <p>Contraindicated in people with G6PD deficiency and in pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level</p></div></td></tr><tr class="odd"><td><span id="v56250155" class="anchor"></span><div class="para"> <p>For terminal prophylaxis to prevent relapse of infection in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel</p></div></td><td><span id="v56250159" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250161" class="anchor"></span><div class="para"> <p>Dosed as above</p></div></td><td><span id="v56250163" class="anchor"></span><div class="para"> <p>Given daily for 14 days after departure from endemic area. Document that the G6PD level is normal before use</p></div><span id="v56250164" class="anchor"></span><div class="para"> <p>Contraindications as above</p></div></td></tr><tr class="even"><td rowspan="2"><span id="v56250167" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tafenoquine</span></p></div></td><td><span id="v56250169" class="anchor"></span><div class="para"> <p>For primary prophylaxis in travelers to all areas</p></div></td><td><span id="v56250171" class="anchor"></span><div class="para"> <p>200 mg once a day for 3 days before travel as a loading regimen, then 200 mg once weekly for maintenance while in the malaria region starting 7 days after the last loading dose, then a 200 mg final dose after exit 7 days following the last maintenance dose</p></div></td><td><span id="v56250173" class="anchor"></span><div class="para"> <p>For patients ≥ 16 years</p></div></td><td rowspan="2"><span id="v56250175" class="anchor"></span><div class="para"> <p>G6PD deficiency or unknown G6PD status; all patients should be tested for G6PD deficiency prior to use</p></div><span id="v56250176" class="anchor"></span><div class="para"> <p>Pregnant and breastfeeding women unless the breastfed infant has a normal G6PD level; known hypersensitivity</p></div><span id="v56250177" class="anchor"></span><div class="para"> <p>Psychiatric adverse reactions have been observed</p></div><span id="v56250178" class="anchor"></span><div class="para"> <p>Use with caution in patients with a history of psychiatric illness</p></div></td></tr><tr class="odd"><td><span id="v56250181" class="anchor"></span><div class="para"> <p>For terminal prophylaxis in people with substantial exposure to or infection with <i>P. vivax</i> or <i>P. ovale</i> during travel </p></div></td><td><span id="v56250185" class="anchor"></span><div class="para"> <p>300 mg single dose </p></div></td><td><span id="v56250187" class="anchor"></span><div class="para"> <p>Not for patients < 18=""></p></div></td></tr></tbody> <tfoot><tr><td colspan="5"><span id="v56250041" class="anchor"></span><div class="para"> <p><sup>a </sup>Preventive drugs are given orally. See table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"28959100-f1d1-4fea-9e6e-9f821fc96776","Title":"Adverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs","ShareUrlTitle":"adverse-reactions-and-contraindications-of-antimalarial-drugs","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v55475990","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAdverse%20Reactions%20and%20Contraindications%20of%20Antimalarial%20Drugs%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span> for adverse reactions and contraindications.</p></div></td></tr><tr><td colspan="5"><span id="v56250045" class="anchor"></span><div class="para"> <p><sup>b </sup><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is available as a fixed-dose combination tablet: adult tablets (250 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/100 mg proguanil) and pediatric tablets (62.5 mg <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>atovaquone</span>/25 mg proguanil). To enhance absorption, patients should take the drug with food or a milky drink. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Atovaquone/proguanil</span> is contraindicated in patients with a creatinine clearance < 30="" ml/min.="" this="" combination="" is="" not="" recommended="" for="" children="" weighing="">< 5="" kg="" or="" for="" pregnant="" or="" breastfeeding=""></p></div></td></tr><tr><td colspan="5"><span id="v56250048" class="anchor"></span><div class="para"> <p><sup>c</sup> Use of tetracyclines is contraindicated during pregnancy and in children <span class='symbol'></span> 8 years.</p></div></td></tr><tr><td colspan="5"><span id="v56250051" class="anchor"></span><div class="para"> <p><sup>d</sup> Physicians should review the prescribing information for <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span> before using it.</p></div></td></tr><tr><td colspan="5"><span id="v56250054" class="anchor"></span><div class="para"> <p><sup>e</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Mefloquine</span> has not been approved for use during pregnancy. The drug is contraindicated in patients who have active depression, a recent history of depression, generalized anxiety disorder, psychosis, schizophrenia, other major psychiatric disorders, or seizures; if patients have psychiatric disturbances or a previous history of depression, the drug should be used cautiously. The drug is not recommended for patients with cardiac conduction abnormalities.</p></div></td></tr><tr><td colspan="5"><span id="v56250057" class="anchor"></span><div class="para"> <p><sup>f</sup> <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> is used as terminal prophylaxis (radical cure) to reduce risk of relapse in people who have taken <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>hydroxychloroquine</span>, or a drug active against <span class="genericDrug" data-showrollover="false">chloroquine</span>-resistant malaria as treatment or prophylaxis for prolonged exposure to <i>P. vivax</i> and/or <i>P. ovale</i>. Alternatively, a single dose of <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> can be used in patients who have received <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>chloroquine</span> for <i>P. vivax</i> treatment or prophylaxis. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> alone can also be used for primary prophylaxis in people at risk of malaria, particularly that due to <i>P. vivax</i>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Primaquine</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tafenoquine</span> are contraindicated in people with G6PD deficiency and in pregnant or breastfeeding women (unless the breastfed infant has a normal G6PD level).</p></div></td></tr><tr><td colspan="5"><span id="v56250064" class="anchor"></span><div class="para"> <p>G6PD = glucose-6-phosphate dehydrogenase.</p></div></td></tr><tr><td colspan="5"><span id="v56250067" class="anchor"></span><div class="para"> <p>Adapted from the Centers for Disease Control and Prevention <span data-mmanualobjecttype="pubtitle">Yellow Book</span>: <a rel="nofollow" target="_blank" href="http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/malaria">Infectious diseases related to travel: Malaria</a>. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>